Introduction {#s1}
============

Throughout the animal kingdom, stem cells supply tissues with specialized cells. They can do this because they have the unique ability to both replicate themselves (an ability termed self-renewal ([@bib107])) and to simultaneously generate other daughter cells with a more restricted developmental potential. Besides their role in tissue homeostasis, stem cells have also been linked to tumor formation ([@bib96]). They can turn into so-called tumor stem cells that sustain tumor growth indefinitely. The mechanisms that endow tumor stem cells with indefinite proliferation potential are not fully understood.

The fruit fly *Drosophila* has emerged as a genetically tractable system to model tumors in a developmental context and adult tissues ([@bib35]; [@bib40]) as well as to study naturally occurring tumors ([@bib98]; [@bib105]). In the developing CNS, neural stem cells, called neuroblasts (NBs) give rise to most neurons and glial cells of the adult fly brain ([@bib111]). For this, they repeatedly divide into one self-renewing and one differentiating daughter cell ([@bib54]; [@bib84]). Disrupting these asymmetric cell divisions can generate lethal, transplantable brain tumors ([@bib6]; [@bib10]; [@bib18]; [@bib49]; [@bib57]; [@bib67]; [@bib66]; [@bib67]). Importantly, the failure to divide asymmetrically has also been linked to tumorigenesis in mammals, particularly in breast cancer ([@bib25]), myeloid leukemia ([@bib48]; [@bib115]; [@bib122]) and gliomas ([@bib22]).

Most *Drosophila* brain tumors originate from the so-called type II neuroblasts (NBIIs) ([Figure 1A](#fig1){ref-type="fig"}). NBIIs divide asymmetrically into a larger cell that retains NB characteristics and a smaller intermediate neural progenitor (INP). Newly formed immature INPs (iINPs) go through a defined set of maturation steps to become transit-amplifying mature INPs (mINPs). After this, a mINP undergoes 3--6 divisions generating one mINP and one ganglion mother cell (GMC) that in turn divides into two terminally differentiating neurons or glial cells ([@bib7]; [@bib14]; [@bib16]).

![*brat* tumor neuroblast possess increased proliferation potential.\
(**A**) Cartoon depicting a *Drosophila* larval brain (OL optic lobe, VNC ventral nerve cord) harboring different neuroblast populations: mushroom body NBs (grey), type I (NBI, green) and II (NBII, orange) neuroblasts. Close-up shows a NBII lineage (iINP - immature intermediate neural progenitor, mINP - mature INP, GMC - ganglion mother cell) and the typical arrangement of cell types in a NBII clone (left). Proteins (blue) are asymmetrically segregated in NBII and mINP to ensure lineage directionality (right). (**B**) In *brat* mutants, the smaller daughter cell fails to differentiate and after a transient cell cycle block regrows into an ectopic neuroblast (tNB - tumor neuroblast). *brat* tumors continue to grow upon transplantation. (**C**) Representative images of adult host flies injected with FACS-sorted control NBs (GFP+) and *brat* ^RNAi^ tNBs (RFP+) from third instar larvae. Transplantations of brain pieces served as controls.](elife-31347-fig1){#fig1}

Similar to mammalian brain progenitors ([@bib59]), *Drosophila* NBs exit proliferation once they complete a specified temporal program during which they generate different types of morphologically distinct progeny ([@bib45]; [@bib74]; [@bib78]; [@bib95]; [@bib109]). It is thought that their correct temporal identity requires the RNA-binding proteins IGF-II mRNA-binding protein (Imp) and Syncrip (Syp). During early larval stages, Imp levels are high and Syp levels are low. Over time, Imp expression gradually decreases while the amount of Syp increases. This leads to highly Syp-positive NBs with no detectable Imp at the end of larval development. Manipulating these opposing gradients changes the number and type of neurons made ([@bib74]; [@bib95]; [@bib109]).

During each NBII division, a set of cell fate determinants is segregated into the INP ([@bib7]; [@bib14]; [@bib16]) ([Figure 1A](#fig1){ref-type="fig"}). Among those are the Notch inhibitor Numb and the TRIM-NHL protein Brain tumor (Brat) ([@bib6]; [@bib10]; [@bib56]; [@bib67]; [@bib108]). Loss of these cell fate determinants ([@bib4]; [@bib7]; [@bib10]; [@bib35]; [@bib67]; [@bib113]) leads to the generation of ectopic NB-like cells at the expense of differentiated brain cells. Formation of malignant brain tumors has also been observed upon the depletion of downstream factors that normally maintain the INP fate ([@bib33]; [@bib49]; [@bib58]; [@bib114]).

These features make *Drosophila* a model for the stepwise acquisition of tumor stem cell properties. When *numb* or *brat* are inactivated ([Figure 1B](#fig1){ref-type="fig"}), the smaller NBII progeny fails to establish an INP fate ([@bib50]; [@bib67]) and initially enters a long transient cell cycle arrest ([@bib16]; [@bib67]). Only after this lag period, the smaller cell regrows to a NB-sized cell that has acquired tumor stem cell properties and that we therefore refer to as tumor neuroblast (tNB) ([@bib7]; [@bib10]; [@bib16]; [@bib67]). NBIIs and ectopic tNBs are indistinguishable in terms of markers. Both cell populations are characterized by the expression of self-renewal genes and lack differentiation markers ([@bib6]; [@bib10]; [@bib67]), but nevertheless behave differently. Shortly after entering pupal stages, NBs decrease their cell volumes successively with each NB division before they exit the cell cycle and differentiate ([@bib45]; [@bib78]). However, tNBs do not shrink during metamorphosis ([@bib45]) and continue to proliferate even in the adult fly brain ([@bib6]; [@bib75]; [@bib82]; [@bib83]). Moreover, in contrast to wild-type brains, the resulting tumor brains can be serially transplanted into host flies for years ([@bib21]; [@bib35]), indicating the immortality of these tumors.

Similarly, mammalian homologues of *numb* ([@bib25]; [@bib28]; [@bib48]; [@bib89]) and *brat* ([@bib22]; [@bib82]) have been shown to inhibit tumor growth. Furthermore, the human *brat* homologue *TRIM3* is depleted in 24% of gliomas ([@bib15]; [@bib22]) and NUMB protein levels are markedly reduced in 55% of breast tumor cases ([@bib89]). Therefore, results obtained in these *Drosophila* tumor models are highly relevant.

Here, we used the *Drosophila brat* tumor model to investigate how tNBs differ from their physiological counterparts, the NBIIs. Our results indicate that progression towards a malignant state is an intrinsic process in *brat* tNBs that does not correlate with stepwise acquisition of DNA alterations. Transcriptome profiling of larval NBs identified the previously uncharacterized long non-coding (lnc) RNA cherub as crucial for tumorigenesis, but largely dispensable for NB development. Our data show that cherub is the first identified lncRNA to be asymmetrically segregated during mitosis into INPs, where the initial high cherub levels decrease with time. Upon the loss of *brat*, the smaller cherub-high cell reverts into an ectopic tNBs resulting in tumors with high cortical cherub. Molecularly, cherub facilitates the binding between the RNA-binding protein Staufen and the late temporal identity factor Syp and consequently tethers Syp to the plasma membrane. Depleting *cherub* in *brat* tNBs leads to the release of Syp from the cortex into the cytoplasm and represses tumor growth. Our data provide insight into how defects in asymmetric cell division can contribute to the acquisition of tumorigenic traits without the need of DNA alterations.

Results {#s2}
=======

Intrinsic mechanisms render tumor neuroblasts immortal {#s2-1}
------------------------------------------------------

Transplanted *brat* tumors have the ability to indefinitely grow in wild-type host flies in contrast to injected control brains ([@bib21]). However, it is unclear whether the proliferation potential of tNBs is an intrinsic feature or an altered response to signals from the brain niche. For this purpose, we transplanted NBs, isolated from other brain cells by Fluorescence-activated cell sorting (FACS), into adult host flies. This procedure also allows the transplantation of equivalent NB numbers for each condition in contrast to the different NB quantities of wild-type compared to *brat* depleted brain pieces. Similar to the transplantation of tissue fragments, only *brat* ^RNAi^ tNBs formed tumors in host flies, whereas control NBs did not ([Figure 1C](#fig1){ref-type="fig"}). Thus, *brat* ^RNAi^ tNBs require intrinsic mechanisms that render them immortal.

Whole genome sequencing reveals no recurrent DNA alterations in tumor neuroblasts {#s2-2}
---------------------------------------------------------------------------------

It is generally assumed that tumorigenesis involves multiple DNA mutations affecting proliferation control pathways ([@bib42]). Nonetheless, the events leading to malignant transformation in *brat* mutants could be genetic or (post)transcriptional. To distinguish between these possibilities, we analyzed the DNA content of cells from tumor and control brains by Hoechst staining and subsequent FACS analyses. In larval and adult stages, tumor brains, similar to control brains, showed two peaks corresponding to diploid (G0/1 phase) and tetraploid (G2/M phase) karyotypes ([Figure 2A](#fig2){ref-type="fig"}). Although *brat* tumor cells showed an increase in tetraploid cells due to more dividing cells, we did not observe any aneuploid and polyploid karyotypes ([Figure 2A](#fig2){ref-type="fig"}).

![*brat* tumors form independently of common DNA alterations.\
(**A**) DNA content analysis of *brat ^k06028^* mutant and control brains showing non-dividing (2n) and mitotic cells (4n). DNA content for each genotype is shown separately in small boxes. (**B--F**) Genome sequencing of *brat*^k06028^ brains and abdominal tissue (control). Note that *Drosophila* brain cells are diploid while the control samples harbor endo-replicating tissue and follicle cells with increased DNA copy number. (**B**) A representative coverage plot of chromosome arm 2L of one tumor is shown (top row), together with datasets indicating under-replicated (blue) and amplified (magenta) genomic regions. (**C**) Close-ups of boxes marked in (**B**) showing steady tumor coverage (red) and a drop (under-replication) or increase (amplification) in the coverage of the control sample (green). (**D**) Genes with identified somatic point mutations (coverage tumor \>14 and control \>8, allelic frequency ≥0.1) of three tumors do not overlap. (**E**) Affected genomic regions of identified small InDels. (**F**) In tumor 2 and 3, one small InDel each was identified in an exon with low allelic frequency. Affected genes are indicated.](elife-31347-fig2){#fig2}

To investigate potential tumor-specific DNA alterations in more detail, we sequenced the genome of three adult brain tumors from hypomorphic *brat ^k06028^* mutants and compared it to that of tumor-free abdominal tissue from the same flies. To identify large genomic aberrations we compared the coverage of tumor versus control samples across the genome. As exemplified for the chromosome arm 2L ([Figure 2B](#fig2){ref-type="fig"}), several regions show differential coverage. However, all of these correspond to regions of the *Drosophila* genome that are known to be either amplified in follicle cells ([@bib27]) or under-replicated in adult polytene cells ([@bib86]), which are present in the abdomen but not in the brain. Thus, these copy number variations are not tumor-specific, but rather due to comparing different tissues ([Figure 2B,C](#fig2){ref-type="fig"}).

Besides that, tumor brains showed no recurrent amplifications or depletions of large chromosome regions, although the detection of afore mentioned biological phenomena shows the ability to detect gross chromosomal aberrations. Similarly, the few detected somatic point mutations did not overlap between the three tumor samples ([Figure 2D](#fig2){ref-type="fig"}). Small insertions and deletions (InDels) were mainly restricted to introns or intergenic regions ([Figure 2E](#fig2){ref-type="fig"}) and we did not identify regions (length 10000 bp) with such InDels common to all three tumor samples. For example, the two InDels affecting exons were identified in separate tumor samples and did not affect the same gene ([Figure 2F](#fig2){ref-type="fig"}). Our data of primary *brat^k06028^* tumors did not reveal recurrent DNA alterations among several tumors nor could we detect abnormal karyotypes. These results suggest that malignant transformation is unlikely to be regulated through a stepwise acquisition of DNA mutations. Thus, the cell-autonomous events leading to highly proliferative tNBs seem to be of transcriptional or post-transcriptional nature.

The lncRNA cherub is upregulated in tumor neuroblasts compared to type II neuroblasts {#s2-3}
-------------------------------------------------------------------------------------

To identify genes involved in brain tumorigenesis, we determined the transcriptomes of FACS-sorted tNBs and NBIIs ([Figure 3A](#fig3){ref-type="fig"}). As larval fly brains contain only 16 NBIIs, we developed a method that combines transposase fragmentation with molecular barcodes (DigiTAG) to derive high quality transcriptome data from low amounts of input RNA ([Figure 3B](#fig3){ref-type="fig"}). In total, we found 1372 up- and 345 downregulated genes in tNBs compared to NBIIs (FDR 0.01, log2fold change ≤ −2 and ≥2, respectively) ([Figure 3C](#fig3){ref-type="fig"}). As a quality control, we successfully verified transcriptional changes of *brat* and fifteen genes with a range of different expression levels by quantitative PCR (qPCR) ([Figure 3---figure supplement 1A--C](#fig3s1){ref-type="fig"}). In contrast to previous whole brain expression datasets ([@bib19]), using defined cell populations in our transcriptome analysis allowed us to identify tNB-specific expression changes. The upregulated gene most highly expressed in tNB was *CR43283* ([Figure 3C](#fig3){ref-type="fig"}), which encodes three alternatively spliced polyadenylated transcripts without any long open reading frames. Peptides of short open reading frames found in CR43283 were not detected in the *brat* tumor proteome ([@bib53]) (data not shown) and PhyloCSF analysis of *CR43283* did not reveal any coding potential ([Figure 3D](#fig3){ref-type="fig"}). Thus, *CR43283* likely acts as a lncRNA. To indicate its *brat* antagonizing activity (see below), we renamed *CR43283* into *cherub*, the antonym for *brat*.

![The lncRNA *CR43283* is upregulated in *brat* tumor neuroblasts.\
(**A**) Cartoon illustrating the strategy to isolate NBII and tNBs. (**B**) Schematic overview of DigiTAG. cDNA fragments of the sequencing library harbor random 8-mer index tags (barcodes) unique for each individual molecule. After sequencing, reads are mapped and barcodes are assigned to each read. Reads with identical barcodes are removed to avoid amplification biases. (**C**) Scatter plot showing the expression in tNBs and NBIIs of genes detected by DigiTAG. Genes significantly up- or downregulated are shown in black (FDR 0.01, p\<0.01), genes unchanged in expression levels in grey. *CR43283* (*cherub*) is highlighted in red. (**D**) Protein coding genes show positive CSF scores, *CR43283* has a negative CSF score (non-coding) similar to well known lncRNAs (roX1, CRG). CSF score for each isoform of a gene is depicted.](elife-31347-fig3){#fig3}

cherub is required for *brat* tumor growth {#s2-4}
------------------------------------------

To analyze *cherub's* function, we inserted FRT sites at the 5' and 3' ends of the longest predicted transcript and generated a deletion by Flp recombination (*cherub* ^DEL^) ([Figure 4---figure supplement 1A--C](#fig4s1){ref-type="fig"}). Our phenotypic analysis also included a promoter deletion created using CRISPR-Cas9 (*cherub* ^promDEL^) and an RNAi construct ([Figure 4---figure supplement 1D](#fig4s1){ref-type="fig"}) to exclude artefacts from deleting DNA elements. *cherub* mutants were viable and fertile, as numbers of eggs laid per female and of emerging adults were similar to control flies ([Figure 4A,B](#fig4){ref-type="fig"}). Furthermore, *cherub* mutant flies showed normal behavior in a geotaxis assay ([Figure 4C](#fig4){ref-type="fig"}). NBII lineages lacking *cherub* appeared normal ([Figure 4D](#fig4){ref-type="fig"}) and contained one large NBII expressing Deadpan (Dpn) but not Asense (Ase) surrounded by Dpn^-^Ase^-^ immature and Dpn^+^Ase^+^ mature INPs ([Figure 4E,F](#fig4){ref-type="fig"}). Nevertheless, in a *cherub* mutant background neither *brat* mutations nor *brat* ^RNAi^ resulted in the formation of large brain tumors ([Figure 5A,B](#fig5){ref-type="fig"}, [Figure 5---figure supplement 1A](#fig5s1){ref-type="fig"}). Both, tumor volumes and numbers of Dpn^+^ tNBs were strongly reduced ([Figure 5---figure supplement 1B](#fig5s1){ref-type="fig"}). The reduction in tumor growth resulted in increased viability ([Figure 5C](#fig5){ref-type="fig"}, [Figure 5---figure supplement 1C](#fig5s1){ref-type="fig"}). A genomic rescue construct was able to again increase the number of Dpn^+^ tNBs in *cherub brat* depleted brains ([Figure 5---figure supplement 1D](#fig5s1){ref-type="fig"}). Thus, cherub is required for tNBs to form large brain tumors.

![*cherub* is dispensable for brain development.\
(**A**) Assessment of female fecundity. For each genotype n = 3 independent crosses. Data are mean ±SD. One-way ANOVA. Not significant (n.s.). (**B**) Fertility and viability of *cherub* mutants shown as percentage of collected eggs giving rise to adult flies. Per genotype n = 10 replicates each consisting of 100 collected eggs. Data are mean ±SD. (**C**) Quantification of the negative geotaxis behavior in *cherub* mutants and control. For each genotype n = 10 replicates, each consisting of 10 adult flies. Data are mean ±SD. One-way ANOVA, not significant (n.s.). (**D**) NBII lineages (outline) of one brain lobe. NBII marked by Dpn. Dividing NBII show cytoplasmic Dpn staining (arrows). Scale bars 50 μm. (**E**) Close-ups of control and *cherub* mutant NBII lineages (outlined) show one single big Dpn^+^ NBII (arrow), Dpn^-^ Ase^-^ iINP (arrowhead) and Dpn^+^ Ase^+^ mINPs (open arrowheads). Scale bars 10 μm. (**D, E**) UAS-*dcr2; insc*-GAL4, UAS-CD8::GFP was used to outline NB lineages. (**F**) Quantifications of large Dpn^+^ NBIIs (n = 4 brain lobes from four different brains), Ase^-^Dpn^-^ iINPs and Ase^+^ Dpn^+^ mINPs in control (n = 16 lineages from four brain lobes) and *cherub* mutant (n = 20 lineages from four brain lobes) L3 brains. Error bars show mean ±SD. Student's *t*-test. n.s. not significant.](elife-31347-fig4){#fig4}

![*cherub* is required for *brat* tumorigenesis.\
(**A, B**) Brain lobes (outlined) stained for Dpn (NB marker) and Ase (differentiating cells). OL, optic lobe. Scale bars 50 μm. Driver line was UAS-*dcr2; insc*-GAL4, UAS-CD8::GFP. (**C**) Percentage of hatched adult flies. *brat* ^RNAi^ flies were crossed to *insc*-GAL4/*CyO*. Flies with *brat* ^RNAi^ that inherit the balancer *CyO* hatch, but those with *insc*-GAL4 die. *cherub* mutants rescue the survival of *insc*-GAL4 + *brat* ^RNAi^ expressing flies. n = 2 independent experiments per genotype. For each genotype per experiment ≥50 flies were counted. Data are mean ±SD.](elife-31347-fig5){#fig5}

cherub is unequally distributed during neuroblast mitosis through binding to the RNA-binding protein Staufen {#s2-5}
------------------------------------------------------------------------------------------------------------

Since the subcellular localization of lncRNAs is often associated with their function ([@bib23]), we visualized the expression of *cherub* in NBII lineages using a single-molecule FISH technique. *cherub* was expressed in all central brain and ventral nerve cord NB lineages ([Figure 6---figure supplement 1A](#fig6s1){ref-type="fig"}).

In NBIIs, FISH probes against cherub stained two nuclear dots ([Figure 6A](#fig6){ref-type="fig"}) representing nascent transcripts ([@bib69]). In addition, the lncRNA was enriched at the cell cortex and was only weakly detected in the cytoplasm ([Figure 6A](#fig6){ref-type="fig"}). The highest levels of *cherub* were found in newborn INPs, where it was cytoplasmic ([Figure 6A,B](#fig6){ref-type="fig"}). Over time, *cherub* expression in INPs decreased and the lncRNA was only weakly detected in GMCs and neurons ([Figure 6B](#fig6){ref-type="fig"}). The majority of NBs cease their proliferation in early pupal stages and terminally differentiate ([@bib46]). Consequently, adult brains showed no expression of *cherub* ([Figure 6---figure supplement 1B](#fig6s1){ref-type="fig"}). Notably, this expression pattern and the localization of cherub was conserved in other *Drosophila* species ([Figure 6---figure supplement 1C,D](#fig6s1){ref-type="fig"}).

![The RNA-binding protein Staufen segregates cherub asymmetrically into the INP upon cell division.\
(**A**) Close-up images of NB clones in interphase. In NBs (arrowhead) cherub FISH signal is detected as two dots and cortically enriched. Nearest daughter cells (arrows) show high cherub levels in the cytoplasm. Scale bars 20 μm. (**B**) Close-up of a NBI and a NBII lineage. Cell types are defined by cell size and the marker combination of Dpn and Ase according to the cartoon. Newly born Dpn^-^ iINPs (open arrowhead) have higher cherub levels than older Dpn^+^ Ase^+^ mINPs (arrowhead). Mitotic INPs show uniform cytoplasmic cherub localization (arrow). (**C**) Close-up images of cherub localization in a mitotic NBII outlined by membrane-bound GFP in vivo. Scale bar 10 μm. (**D**) Representative image of a dividing NBII in vitro. 100% of mitotic NBIIs show cherub crescents (**E**) opposite to the apical aPKC crescent as measured by the angle between aPKC and cherub crescents. An angle of 180° corresponds to crescents opposite each other. n = 23 NBIIs. Scale bar 10 μm. (**F**) Expressing constitutively active Lgl (Lgl^3A^) leads to a uniformly cortical distribution while constitutively active aPKC (aPKC^ΔN^) or *miranda (mira)* knockdown displaces cherub from the cell cortex. Scale bars 10 μm. (**G**) Ratios of cytoplasmic cherub intensity of INP (or daughter cell) and NBII are depicted. In control, asymmetric cell division leads to higher cherub levels in INPs (n = 11 NB-INP pairs from four different brains). Upon the expression of aPKC^ΔN^ (n = 11 NB-daughter cell pairs from four different brains) or *miranda* ^RNAi^ (n = 12 NB-daughter cell pairs from four different brains), cherub levels are similar in NBIIs and their recently born (closest) daughter cell. Data are mean ±SD. (**H**) cherub localization in control and upon *staufen* knockdown. Brain lobes (top) and NBII (bottom) are outlined. Scale bars 50 and 10 μm. Driver line was UAS-*dcr2; insc*-GAL4, UAS-CD8::GFP. (**I**) In contrast to control (n = 13 NBII-INP pairs of 4 different brains), *staufen* depletion leads to similar cytoplasmic cherub levels between INP and NBII (n = 15 NBII-INP pairs of 4 different brains). Data are mean ±SD. (**J**) RIP-qPCR analysis for *cherub* and the non-Staufen target *RpL32.* Note that brain lysates from *brat* ^k06028^ mutants were used to enrich for NBs as cherub is only cortically localized in NBs. Data are mean ±SD. n = 3 independent RIP-qPCR experiments, Student's *t*-test. \*p\<0.05. (**K**) Cartoon of a mitotic NB with apical and basal crescents. Close-up of the basal crescent (right) shows that the Staufen-Miranda complex localizes cherub to the plasma membrane.](elife-31347-fig6){#fig6}

Remarkably, the cortical pool of cherub localized asymmetrically in mitotic NBs, opposite to the apical marker aPKC and thus segregated into the INP upon cytokinesis ([Figure 6C](#fig6){ref-type="fig"}). To avoid false positive cherub crescents due to surrounding cherub high daughter cells, we additionally confirmed the basal localization of cherub in isolated NBIIs in vitro ([Figure 6D,E](#fig6){ref-type="fig"}, [Video 1](#video1){ref-type="video"}).

###### cherub is restricted to the basal cell pole of mitotic type II neuroblasts.

3D reconstruction of a representative z-stack showing a NBII marked with the apical marker aPKC (white), mitotic marker PH3 (cyan) and cherub (red). First view shows the raw fluorescence signal followed by the display of reconstructed surfaces. NBIIs were harvested from dissociated brains and arrested in mitosis using Colcemid.

10.7554/eLife.31347.015

Among all three *cherub* isoforms, only isoform RC can be unambiguously detected. However, the combination of FISH probes against specifically RC and regions present in RA and RC or RB and RC confirmed that all isoforms showed the same localization pattern and were asymmetrically segregated in NBIIs during mitosis ([Figure 6---figure supplement 1E--K](#fig6s1){ref-type="fig"}).

Previous work has shown that during mitosis the apical aPKC-Par complex releases Lethal (2) giant larvae (Lgl) from the apical side of the cell, which then promotes the localization of factors to the basal cell pole ([@bib9]; [@bib66]). To determine whether this mechanism is involved in cherub polarization during cell division, components of the apical as well as of the basal domain were misexpressed or knocked down by RNAi. While expressing a constitutively active form of Lgl (Lgl3A) led to a uniform cortical localization of cherub, the overexpression of a constitutively active form of aPKC (aPKC∆N) resulted in cytoplasmic cherub ([Figure 6F](#fig6){ref-type="fig"}). Additionally, cherub transcripts became enriched in the nearest daughter cells of the NBII in control brains, but upon aPKC∆N expression cherub concentrations were comparable between both cells ([Figure 6G](#fig6){ref-type="fig"}), indicating symmetric distribution of cherub. From these results, we conclude that the canonical asymmetric cell division machinery establishes the unequal partitioning of cherub between daughter cells.

Basal cherub polarity depended on Miranda ([Figure 6F,G](#fig6){ref-type="fig"}), a known adaptor protein required to tether proteins to the basal part of a NB's plasma membrane. As Miranda does not possess any RNA-binding domains, one of the proteins transported by Miranda might localize cherub. The Miranda-associated RNA-binding protein Staufen ([@bib77]; [@bib100]; [@bib101]; [@bib106]) has been described to enrich at the basal cell pole of dividing embryonic and larval NBs ([@bib17]; [@bib51]; [@bib70]) and indeed it also localized asymmetrically in dividing NBIIs ([Figure 6---figure supplement 2A](#fig6s2){ref-type="fig"}). Consequently, Staufen was enriched in the most recently born iINPs and declined upon INP differentiation ([Figure 6---figure supplement 2B](#fig6s2){ref-type="fig"}). In *staufen* depleted NBIIs, cherub was no longer cortical, failed to segregate asymmetrically and accumulated in the cytoplasm ([Figure 6H,I](#fig6){ref-type="fig"}, [Figure 6---figure supplement 2C](#fig6s2){ref-type="fig"}). qPCR on RNA, isolated from anti-Staufen immunoprecipitates, detected *cherub* but not the highly expressed control RNA *RpL32* ([Figure 6J](#fig6){ref-type="fig"}). In-silico analysis of cherub transcripts showed limited sequence similarity across *Drosophila* species ([Figure 6---figure supplement 3A,B](#fig6s3){ref-type="fig"}), but revealed four thermodynamically stable and evolutionary conserved secondary RNA structures ([Figure 6---figure supplement 3A,C](#fig6s3){ref-type="fig"}). The identified structures resemble stem loops previously described for Staufen binding ([@bib34]; [@bib63]) and hence may constitute potential binding sites. Notably, in some species base-pairing nucleotides were mutated in such a way to still allow base-pairing ([Figure 6---figure supplement 3C](#fig6s3){ref-type="fig"}). This indicates that the structure rather than the sequence is preserved, which is in accordance with the fact that Staufen binds double-stranded structures and not a specific sequence motif ([@bib94]). Therefore, binding to Staufen is required for segregating cherub into INPs to prevent its accumulation in NBIIs over time ([Figure 6K](#fig6){ref-type="fig"}).

*cherub* accumulates in *brat* tumor neuroblasts {#s2-6}
------------------------------------------------

To understand how high levels of cherub emerge in *brat* tumors, we utilized the ability to detect both, nascent nuclear and cortical cherub by FISH. Intensity measurements of nuclear cherub dots, which represent transcribed RNA ([Figure 7---figure supplement 1A](#fig7s1){ref-type="fig"}), did not reveal any significant increase in *brat* ^RNAi^ tNBs ([Figure 7A](#fig7){ref-type="fig"}). This suggests that high levels are not due to transcriptional upregulation. Cortical cherub, in contrast, was strongly enhanced in *brat* tNBs ([Figure 7B](#fig7){ref-type="fig"}, [Figure 7---figure supplement 1B](#fig7s1){ref-type="fig"}) and still asymmetrically inherited by one daughter cell in the majority of tNBs ([Figure 7C,D](#fig7){ref-type="fig"}).

![The asymmetrically segregated lncRNA *cherub* accumulates in *brat* tumor neuroblasts.\
(**A**) Intensity measurements of nascent cherub transcript in NBIIs (n = 43 NBs) and *brat* tNBs (n = 43 tNBs) from three independent FISH experiments. Student's *t*-test. Not significant (n.s.) p\>0.05. (**B**) cherub localization in a *brat* mutant brain lobe (left, scale bar 100 µm) and close-up of tNBs (right, scale bar 20 µm). (**C**) Quantification of the angle between aPKC and cherub crescents of mitotic tNBs in vitro. An angle of 180° corresponds to a basal cherub crescent. n = 23 mitotic tNBs. Mean ±SD is shown. (**D**) Representative image of a mitotic tNB in vitro. Scale bar 10 μm. Percentage of tNBs showing a cherub crescent during cell division is indicated. n = 82 mitotic tNBs. (**E, F**) *cherub* expression in NBII clones (outlined) induced with the TARGET system for 24 hr (**E**) or 72 hr (**F**). Arrowheads exemplify Dpn^+^ tNBs and the open arrowhead marks the NBII. Scale bars 20 μm. UAS transgenes are expressed by UAS-*dcr2; wor-*GAL4, *ase*-GAL80; UAS-CD8::GFP. (**G**) Quantification of cortical cherub intensity after 72 hr clone induction. Control n = 7 NBIIs and *brat* ^RNAi^n = 16 tNBs. Data are mean ±SD. Student's t-test and \*\*\*\*p\<0.0001.](elife-31347-fig7){#fig7}

To understand how cherub ^high^ tNBs arise, we used a temperature sensitive system to induce *brat* ^RNAi^ for a defined time to follow cherub accumulation upon *brat* depletion over time. After 24 hr, *brat* ^RNAi^ NBIIs form iINPs that do not differentiate into mINPs and therefore do not re-enter the cell cycle ([@bib16]). In these *brat* depleted INPs, cherub remained highly expressed and cortical, whereas it became cytoplasmic in control INPs ([Figure 7E](#fig7){ref-type="fig"}). After 48 hr, *brat* ^RNAi^ iINPs revert into supernumerary Dpn^+^, Ase^-^ NBIIs and initiate tumor formation. Whereas control INPs started to downregulate cherub, these extra tNBs had strongly elevated cortical cherub ([Figure 7F,G](#fig7){ref-type="fig"}), presumably because the lncRNA was not released into a differentiating cell in which cherub levels gradually decrease. Hence, cherub accumulates in tNBs, because these supernumerary NBs arise from the daughter cells that carry high levels of cherub.

Tumor neuroblasts show defects in temporal neuroblast identity and require early temporal factors {#s2-7}
-------------------------------------------------------------------------------------------------

Over time, *Drosophila* NBs express distinct sets of genes, which confer distinct temporal identities. A temporal fate allows NBs to generate neurons with different axonal projection patterns during development and is important for their timely cell cycle exit ([@bib45]; [@bib59]; [@bib74]; [@bib78]). Moreover, the molecular NB clock has been shown to be important for generating malignant tumors. When tumors are induced early in development tumor cells are generated that drive tumor proliferation even at later developmental stages due to the failure to turn-off early growth-promoting genes ([@bib83]).

Although tNBs used for transcriptome analysis were collected at late larval stages, they still expressed genes usually restricted to early NBs (24--50 hr after larval hatching) ([@bib74]), among them the early NB identity gene *Imp* ([Figure 8A](#fig8){ref-type="fig"}). Temporal identity in NBIIs is controlled by opposing gradients of the RNA-binding proteins Imp and Syp ([Figure 8B](#fig8){ref-type="fig"}) ([@bib95]; [@bib109]). The transition from early Imp-positive to a late Syp-positive NB state is triggered by the nuclear receptor Seven-up (Svp) ([@bib83]; [@bib95]; [@bib109]).

![Temporal neuroblast identity controls *brat* tumor growth.\
(**A**) The expression of genes characteristic for a young NB identity are upregulated in tNBs compared to control NBIIs. Depicted is the log2 foldchange in expression of NBIIs versus tNBs. (**B**) Cartoon depicting the control of larval temporal NB identity by opposing RNA-binding protein (RBP) gradients (**C**) Expression of the early NB identity gene *Imp* in *brat* ^RNAi^ and *brat* ^RNAi^*cherub* ^DEL/promDEL^ tNBs. (**D**) Syncrip localization in *brat* ^RNAi^ and *brat* ^RNAi^*cherub* ^DEL/promDEL^ tNBs. (**C, D**) Scale bars 10 μm. Driver line UAS-*dcr2; wor*-GAL4, *ase*-GAL80; UAS-CD8::GFP. Membrane-bound GFP outlines tumor tissue. (**E, F**) Survival rates of adult flies bearing primary control tumors or rejuvenated (orange) or aged (purple) *brat* tumors. Student's *t*-test. \*\*\*\*p\<0.0001, n ≥ 4 independent survival experiments. 50% survival rate shown as mean ±SD. (**G, H**) Overview of *brat* brain lobes (outlined) stained with the NB marker Dpn upon downregulation of *Imp* (**G**) or *Syp* (**H**). Scale bars 50 μm. (**I, J**) Quantification of tumor volume from three independent experiments. Data are mean ±SD. Student's *t*-test. \*\*\*\*p\<0.0001. (**I**) Knockdown of *Imp* (n = 15 brain lobes) results in smaller tumors compared to control tumors (n = 13 brains lobes). (**J**) Tumors with reduced Syp levels (n = 15 brain lobes) are larger than control tumors (n = 14 brain lobes). (**E--J**) Transgenes were expressed using the NBII-specific driver line UAS-*dcr2; wor*-GAL4, *ase*-GAL80; UAS-CD8::GFP.](elife-31347-fig8){#fig8}

To investigate whether tNBs might be defective in temporal NB identity, we analyzed the temporal gene expression signature of *brat* mutant tNBs. Indeed, antibody staining for the early temporal factor Imp confirmed that *brat* tumors contain tNBs of early temporal identity ([Figure 8C](#fig8){ref-type="fig"}). Interestingly, the formation of tNBs with an early temporal identity was dependent on *cherub* as upon the depletion of *cherub* Imp-positive tNBs are no longer present ([Figure 8C](#fig8){ref-type="fig"}). On the other hand, the late temporal identity factor Syp was also present in tNBs, but rather than being mainly cytoplasmic in late NBs as previously described ([@bib74]), Syp was enriched at the cell cortex ([Figure 8D](#fig8){ref-type="fig"}). *brat* tumors depleted of *cherub* still expressed Syp, however Syp was no longer enriched at the cell cortex ([Figure 8D](#fig8){ref-type="fig"}). Thus, *brat* mutant tNBs fail to fully progress to the late stages of temporal identity in a cherub-dependent manner.

We hypothesized that if temporal identity defects contribute to tumor proliferation, 'aging' or 'rejuvenating' tNBs should have an effect on tumor growth and survival of tumor-bearing flies.

Advancing tNBs' temporal identity by *svp* overexpression ([Figure 8---figure supplement 1A--C](#fig8s1){ref-type="fig"}) or *Imp* depletion by RNAi ([Figure 8E,G,I](#fig8){ref-type="fig"}) significantly reduced tumor growth and increased the median survival time (50% survival rate) of tumor-bearing flies. Conversely, shifting temporal identity of *brat* ^RNAi^ tNBs towards younger stages by *svp* misexpression ([Figure 8---figure supplement 1A](#fig8s1){ref-type="fig"}) or *Syp* ^RNAi^ ([Figure 8](#fig8){ref-type="fig"} - F, H, J) significantly decreased the median survival rates indicating faster tumor growth. Thus, temporal identity defects are involved in brain tumor growth.

cherub facilitates the interaction between Staufen and late temporal identity factor Syncrip {#s2-8}
--------------------------------------------------------------------------------------------

Since the cortical localization of Syp is cherub-dependent in tNBs, it is tempting to speculate that cherub acts as an adapter to facilitate the binding between Staufen and Syp. This assumption implies that firstly Syp shows a similar localization pattern to Staufen and cherub and secondly Syp segregates asymmetrically via Staufen into iINPs. Indeed, in NBIIs Syp was localized at the cortex and also detected in the cytoplasm ([Figure 9D,E](#fig9){ref-type="fig"}). Similar to Staufen and cherub, Syp segregated asymmetrically in mitosis ([Figure 9A--C](#fig9){ref-type="fig"}), and became enriched in the cytoplasm of the most recently-born INPs ([Figure 9D,E](#fig9){ref-type="fig"}). Furthermore, Syp colocalized with Staufen and cherub in mitotic NBIIs ([Figure 9---figure supplement 1A--G](#fig9s1){ref-type="fig"}). In *cherub* mutants or upon *staufen* knockdown, Syp was exclusively cytoplasmic and no longer cortical ([Figure 9D,E](#fig9){ref-type="fig"}). These results indicate that Syp is recruited to the cortex by the cherub-Staufen complex.

![cherub facilitates the binding between Staufen and the late temporal factor Syncrip.\
(**A**) Syncrip (Syp) localization in a mitotic NB (outlined) in vivo. Scale bar 10 μm. (**B**) Representative image and percentages of mitotic NBIIs in vitro showing Syp crescents. n = 17 mitotic NBIIs. Scale bar 10 μm. (**C**) Angle measurement between Syp and apical aPKC crescents. n = 17 mitotic NBIIs. Mean ±SD is shown. (**D, E**) Syp is delocalized in NBIIs (open arrowhead) and cytoplasmic enrichment in newly born INPs (arrowhead) is lost in *cherub* mutants (**D**) or upon Staufen reduction (**E**). Scale bars 20 μm. (**E**) UAS-*dcr2; insc*-GAL4, UAS-CD8::GFP was used. (**F**) Immunoprecipitation of Staufen in the presence and absence of cherub. (**G**) Immunoprecipitation of expressed HA-tagged Syp in the presence and absence of RNase treatment. (**H**) RIP-qPCR analysis of *cherub* and the negative control *RpL32* upon Syp-HA pull down. Student's t-test, \*\*p\<0.01, n = 3 independent RIP-qPCR experiments, depicted as mean ±SD. (**F--H**) Brain lysates from *brat* ^RNAi^ tumors and *brat* ^RNAi^ *cherub ^DEL-/-^* or *brat* ^RNAi^ UAS-Syp-HA were used to enrich for NBs. Driver line used was UAS-*dcr2; wor-*GAL4, *ase*-GAL80; UAS-CD8::GFP. (**I**) Cartoon summarizing the role of cherub in Miranda-Staufen-Syncrip complex formation.](elife-31347-fig9){#fig9}

To further confirm the role of cherub in Staufen-Syp complex formation, we performed immunoprecipitation experiments on brain lysates from *brat* tumors. Co-immunoprecipitation experiments demonstrated that Staufen and Syp are in a complex and binding between the two proteins was lost upon RNA digestion or *cherub* depletion ([Figure 9F,G](#fig9){ref-type="fig"}). RIP-qPCR experiments further confirmed that cherub was enriched upon HA-tagged Syp pull-down ([Figure 9H](#fig9){ref-type="fig"}). These data suggest that cherub functions as adapter between Syp and Staufen ([Figure 9I](#fig9){ref-type="fig"}).

Discussion {#s3}
==========

Tumor cells display features not normally found in healthy cells. How those features arise and how they can be exploited to combat tumorigenesis are important questions in tumor biology. Here we show that the lncRNA *cherub* regulates a critical step in *Drosophila* brain tumorigenesis, but is dispensable for normal development. During each division, cherub is depleted from the NB and is segregated into the differentiating daughter cells by binding to the RNA-binding protein Staufen. During tumor formation, however, de-differentiation of the cherub-high cells results in the formation of tumor NBs with extraordinarily high cherub levels. We show that cherub induces the formation of a cortical complex between Staufen and Syp, a conserved RNA-binding protein ([@bib79]) required for NBs to acquire late temporal identity ([@bib74]; [@bib95]; [@bib109]). Our data suggest that temporal identity defects contribute to tumor formation and reveal a new function for lncRNAs in controlling the subcellular localization of protein determinants.

The malignant transformation of *brat* tumor neuroblasts is regulated by epigenetic mechanisms {#s3-1}
----------------------------------------------------------------------------------------------

It is commonly assumed that cancer cells become malignant and gain replicative immortality by acquiring genetic lesions ([@bib42]). Surprisingly, however, our data indicate that *brat* tumors do not require additional genetic lesions for the transition to an immortal state. This is not a general feature of *Drosophila* tumors as genomic instability alone can induce tumors in *Drosophila* epithelial cells ([@bib31]) and intestinal stem cells ([@bib105]). However, our results are supported by previous experiments demonstrating that defects in genome integrity do not contribute to primary tumor formation in NBs ([@bib20]). Similarly, tumors induced by loss of epigenetic regulators in *Drosophila* wing discs do not display genome instability ([@bib104]). In addition, the short time it takes from the inactivation of *brat* to the formation of a fully penetrant tumor phenotype would most likely be insufficient for the acquisition of tumor-promoting DNA alterations. More likely, the enormous self-renewal capacity and fast cell cycle of *Drosophila* NBs requires only minor alterations for the adoption of malignant growth. Interestingly, epigenetic tumorigenesis was described before in humans, where childhood brain tumors only harbor an extremely low mutation rate and very few recurrent DNA alterations ([@bib68]; [@bib76]; [@bib87]; [@bib88]; [@bib91]; [@bib97]; [@bib99]; [@bib116]; [@bib120]). Comparable observations have been made for leukemia ([@bib92]; [@bib117]). Our results might help to understand mechanisms of epigenetic tumor formation, which are currently unclear in humans.

cherub is the first lncRNA known to segregate asymmetrically {#s3-2}
------------------------------------------------------------

*cherub* is the first lncRNA described to segregate asymmetrically during mitosis. Once cherub is allocated through binding to the RNA-binding protein Staufen into the cytoplasm of INPs, its levels decrease over time. Our results show that the inability to segregate cherub into differentiating cells leads to its accumulation in tNBs. The increasing amount of tumor transcriptome data indicates that a vast number of lncRNAs show increased expression levels in various tumor types ([@bib47]). Intriguingly, the mammalian homologue of cherub's binding partner Staufen has been also described to asymmetrically localize RNA in dividing neural stem cells ([@bib62]; [@bib112]). Hence, besides transcriptional upregulation, asymmetric distribution of lncRNAs between sibling cells might play a role in the accumulation of such RNAs in mammalian tumors.

Defects in temporal identity contribute to tumorigenic growth {#s3-3}
-------------------------------------------------------------

Our data suggest a functional connection between cherub and proteins involved in temporal neural stem cell patterning. We show that tNBs retain the early temporal identity factor Imp even during late larval stages. However, *Imp* expression in *brat* mutants is heterogeneous and only a subpopulation of tNBs maintains young identity.

Tumor heterogeneity has also been described for *pros* tumors, where only a subset of tNBs maintains expression of the early temporal factors Imp and Chinmo ([@bib83]). Interestingly, it is this subpopulation that drives tumor growth in *prospero* tumors.

Consistent with this, our genetic experiments show that 'rejuvenating' tNBs enhances tumor growth and consequently increases the survival of tumor bearing flies, whereas 'aging' tNBs identity has the opposite effect. Although mammalian counterparts of Imp have not yet being shown to act as temporal identity genes, their upregulated expression has been implied in various cancer types ([@bib29]; [@bib64]). Therefore, temporal patterning of NBs has an essential role in brain tumor propagation in *Drosophila.*

cherub regulates Syp locatization in *brat* tumors {#s3-4}
--------------------------------------------------

The subset of tNBs that retain early identity in tumors is lost in a *cherub* mutant background. This suggests that cherub itself might regulate temporal identity. In NBs and tNBs cherub regulates Syp localization by facilitating the binding of Syp to Staufen and thus recruiting it to the cell cortex. In tumors depleted of *cherub*, Syp localizes mainly to the cytoplasm and is no longer observed at the cortex. As the removal of Syp in tNBs leads to enhanced tumor growth and early lethality, those data suggest that cherub could control temporal NB identity by regulating the subcellular localization of Syp.

How could cherub regulate the function of Syp? The RNA-binding protein Syp is a translational regulator ([@bib32]; [@bib79]; [@bib80]) and has been suggested to control mRNA stability ([@bib119]). As mammalian SYNCRIP/hnRNP Q interacts with a lncRNA that suppresses translation ([@bib32]; [@bib60]), cherub might regulate Syp to inhibit or promote the translation of a subset of target mRNAs. In particular, in NBs Syp acts at two stages in NBs during development: Firstly, approximately 60 hr after larval hatching it represses early temporal NB factors, like Imp ([@bib109]; [@bib118]). Secondly, at the end of the NB lifespan Syp promotes levels of the differentiation factor *prospero* to facilitate the NB's final cell cycle exit ([@bib118]; [@bib119]). As *cherub* depletion in *brat* tumors leads to decreased tumor growth ([Figure 5A,B](#fig5){ref-type="fig"}), it is possible that cherub inhibits the Syp-dependent repression of the early factor Imp, which we showed is required for optimal tumor growth ([Figure 8E,G](#fig8){ref-type="fig"}). However, *cherub* mutant NBIIs do not show altered timing or expression of Imp during development (data not shown). In accordance, *brat* tumors show high cortical cherub levels, but only a subset of NBs expresses Imp ([Figure 8C](#fig8){ref-type="fig"}). Rather than rendering Syp completely inactive, we suggest that cherub decreases the ability of Syp to promote factors important to restrict NB proliferation. As *prospero* is not expressed in NBIIs, it remains to be investigated which Syp targets are affected by cherub.

cherub is largely dispensable for normal development {#s3-5}
----------------------------------------------------

Remarkably, *cherub* mutants are viable, fertile and do not affect NBII lineages. Neurons generated by NBIIs predominantly integrate into the adult brain structure termed central complex, which is important for locomotor activity. As *cherub* mutants show normal geotaxis, function of the lncRNA seems dispensable for NBIIs to generate their neural descendants.

Nevertheless, the conserved secondary RNA structures of *cherub* and its conserved expression pattern in other *Drosophila* species suggest that it has a functional role. There are several possibilities why we do not observe a phenotype upon the loss of cherub. In wild-type flies cherub might confer robustness. A similar scenario was observed in embryonic NBs, in which Staufen segregates *prospero* mRNA into GMCs ([@bib17]; [@bib100]). The failure to segregate *prospero* mRNA does not result in a phenotype, but it enhances the hypomorphic *prospero* GMC phenotype ([@bib17]). Thus segregation of *prospero* mRNA serves as support for Prospero protein to induce a GMC fate. Similarly, cherub could act as a backup to reliably establish correct Syp levels in NBIIs and in INPs. Alternatively, cherub might fine-tune the temporal patterning by regulating the cytoplasmic pool of Syp in the NBs. Increasing Syp levels have been suggested to determine distinct temporal windows, in which different INPs and ultimately neurons with various morphologies are sequentially born ([@bib95]). Therefore, we cannot exclude that changes in Syp levels lead to subtle alterations in the number of certain neuron classes produced by NBIIs that only reveal themselves in pathological conditions like tumorigenesis.

Future directions {#s3-6}
-----------------

Our study illustrates how a lncRNA can control the subcellular localization of temporal factors. In addition to temporal NB identity, Syp regulates synaptic transmission and maternal RNA localization ([@bib79]). While *cherub* is not expressed in ovaries or adult heads, Staufen has been implicated in these processes, suggesting that other RNAs might act similarly to *cherub*. Interestingly, the mammalian Syp homolog hnRNP Q binds the noncoding RNA BC200 ([@bib32]), whose upregulation is used as a biomarker in ovarian, esophageal, breast and brain cancer ([@bib30]; [@bib90]; [@bib121]) ([@bib30]; [@bib90]; [@bib121]). In the future, it will be interesting to investigate whether the mechanism we have identified in *Drosophila* is involved in mammalian tumorigenesis as well.

Materials and methods {#s4}
=====================

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type (species)\       Designation                        Source or reference            Identifiers                                                            Additional information
  or resource                                                                                                                                                            
  ----------------------------- ---------------------------------- ------------------------------ ---------------------------------------------------------------------- ---------------------------------------------
  gene (*D. melanogaster)*      cherub                             NA                             FLYB:FBgn0262972                                                       

  gene (*D. melanogaster)*      Syncrip                            NA                             FLYB:FBgn0038826                                                       

  gene (*D. melanogaster)*      Staufen                            NA                             FLYB:FBgn0003520                                                       

  gene (*D. melanogaster)*      Imp                                NA                             FLYB:FBgn0285926                                                       

  antibody                      anti-Deadpan (guinea\              PMID:24630726                                                                                         (1:1000)
                                pig, polyclonal)                                                                                                                         

  antibody                      anti-Elav (rat, monoclonal)        Developmental Studies\         7E8A10, RRID:[AB_528218](https://scicrunch.org/resolver/AB_528218)     (1:200)
                                                                   Hybridoma Bank                                                                                        

  antibody                      anti-Staufen (rat polyclonal)      PMID:19481457                                                                                         (1:100)

  antibody                      anti-Staufen (goat polyclonal)     Santa Cruz Biotechnology       dN-16, sc-15823,\                                                      (1:2000)
                                                                                                  RRID:[AB_661413](https://scicrunch.org/resolver/AB_661413)             

  antibody                      anti-Asense (rat polyclonal)       PMID:24630726                                                                                         (1:500)

  antibody                      anti-HA (mouse monoclonal)         Roche                          clone 12CA5, 11583816001                                               

  antibody                      anti-aPKC (rabbit polyclonal)      Santa Cruz Biotechnology       sc-216, RRID:[AB_2300359](https://scicrunch.org/resolver/AB_2300359)   (1:500)

  antibody                      anti-GFP (chicken polyclonal)      Abcam                          ab13970, RRID:[AB_300798](https://scicrunch.org/resolver/AB_300798)    (1:500)

  antibody                      anti-Miranda (rabbit polyclonal)   PMID:24630726                                                                                         (1:500)

  antibody                      secondary antibody (HRP-linked\    GE Healthcare, Abcam, Santa\   sc-2384, NA931V, ab6908,\                                              1:2000
                                Whole Antibodies)                  Cruz Biotechnologies           RRID:[AB_955425](https://scicrunch.org/resolver/AB_955425),\           
                                                                                                  RRID:[AB_634814](https://scicrunch.org/resolver/AB_634814)             

  antibody                      anti-Syncrip (guinea\              PMID:23213441                                                                                         (1:500)
                                pig polyclonal)                                                                                                                          

  antibody                      anti-PH3(Ser10) (mouse\            Cell Signalling Technologies   9706S, RRID:[AB_331748](https://scicrunch.org/resolver/AB_331748)      (1:1000)
                                monoclonal)                                                                                                                              

  antibody                      Alexa 405, 488, 568, 647           Invitrogen                     Alexa Fluor dyes                                                       (1:1500)

  other                         Hoechst 33342                      Thermo Scientific Fisher       62249                                                                  (20 µM)

  chemical compound             Colcemid                           Enzo Life Sciences             ALX-430--033 M001                                                      (25 µM)

  chemical compound             Protein G Dynabeads                Thermo Scientific Fisher       10004D                                                                 

  Recombinant DNA reagent       genomic cherub region\             Pacman Resources               CH322-116G10,\                                                         
                                (Bac clone)                                                       FLYB:FBcl0758452                                                       

  Recombinant DNA reagent       Walium20 vector                    Plasmid Repository of DNA\     pWalium20                                                              
                                                                   Resource Core(Harvard\                                                                                
                                                                   Medical School)                                                                                       

  other                         FISH probes labeled with\          Biosearch Technologies         cherub all                                                             this study - oligonucleotide\
                                Quasar Dye                                                                                                                               sequence see\
                                                                                                                                                                         Materials and methods

  other                         FISH probes labeled with\          Biosearch Technologies         cherub RA/RC                                                           this study - oligonucleotide\
                                Quasar Dye                                                                                                                               sequence\
                                                                                                                                                                         see Materials and methods

  other                         FISH probes labeled with\          Biosearch Technologies         cherub RB/RC                                                           this study - oligonucleotide\
                                Quasar Dye                                                                                                                               sequence\
                                                                                                                                                                         see Materials and methods

  other                         FISH probes labeled with\          Biosearch Technologies         cherub RC                                                              this study - oligonucleotide\
                                Quasar Dye                                                                                                                               sequence\
                                                                                                                                                                         see Materials and methods

  software,algorithm            JACoP                              PMID:17210054                                                                                         

  software,algorithm            Prism 7                            GraphPad Software              RRID:[SCR_002798](https://scicrunch.org/resolver/SCR_002798)           

  software,algorithm            PhyloCSF                           PMID:21685081                                                                                         

  software,algorithm            FlowJo software                    FlowJo, LLC                    RRID:[SCR_008520](https://scicrunch.org/resolver/SCR_008520)           

  software,algorithm            BWA                                PMID:19451168                  RRID:[SCR_015853](https://scicrunch.org/resolver/SCR_015853)           

  software,algorithm            Picard tools (v1.82)               Broad Institute                RRID:[SCR_006525](https://scicrunch.org/resolver/SCR_006525)           <http://broadinstitute.github.io/picard>

  software,algorithm            GATK (v2.3)                        Broad Institute                RRID:[SCR_001876](https://scicrunch.org/resolver/SCR_001876)           <https://software.broadinstitute.org/gatk/>

  software,algorithm            MuTect (v1.1.4)                    PMID:23396013                  RRID:[SCR_000559](https://scicrunch.org/resolver/SCR_000559)           

  software,algorithm            SnpEff (v3.2a)                     PMID:22728672                  RRID:[SCR_005191](https://scicrunch.org/resolver/SCR_005191)           

  software,algorithm            Published aCGH datasets            PMID:22090375 and 21724831                                                                            

  software,algorithm            TopHat                             PMID:19289445                  RRID:[SCR_013035](https://scicrunch.org/resolver/SCR_013035)           

  software,algorithm            DESeq (v1.10.1)                    PMID:20979621                  RRID:[SCR_000154](https://scicrunch.org/resolver/SCR_000154)           

  software,algorithm            HTSeq                              PMID:25260700                  RRID:[SCR_005514](https://scicrunch.org/resolver/SCR_005514)           

  software,algorithm            Biostrings                         R package version 2.40.2.                                                                             

  commercial assay              Nextera DNA Library\               Illumina                       FC-121--1031                                                           
                                Preparation Kit                                                                                                                          

  commercial assay              Agencourt AMPure XP beads          Beckman Coulter                A63880                                                                 

  commercial assay              TRIzol LS                          Ambion                         10296010                                                               

  commercial assay              NEBNext Ultra DNA\                 Illumina                       E7370S                                                                 
                                Library Prep Kit                                                                                                                         

  commercial assay              Agilent High Sensitivity DNA Kit   Agilent Technologies           5067--4626                                                             

  other                         Rinaldini solution                 PMID:22884370                                                                                         1X

  Peptide                       Staufen Blocking peptide           Santa Cruz Biotechnology       sc-15823P                                                              used 10x amount of\
                                                                                                                                                                         primary antibody

  Peptide                       HA Blocking Peptide                Roche                          11666975001                                                            used 10x amount of\
                                                                                                                                                                         primary antibody

  genetic reagent\              UAS-*brat* ^RNAi^                  Vienna Drosophila\             VDRC:105054 and 31333                                                  
  (*Drosophila melanogaster*)                                      Resource Center                                                                                       

  genetic reagent\              UAS-*mira* ^RNAi^                  PMID:16564014                                                                                         
  (*Drosophila melanogaster*)                                                                                                                                            

  genetic reagent\              UAS-mCherry ^RNAi^                 Bloomington Drosophila\        BDSC:35785,\                                                           
  (*Drosophila melanogaster*)                                      Stock Center                   RRID:[BDSC_35785](https://scicrunch.org/resolver/BDSC_35785)           

  genetic reagent\              UAS-*aPKC*^ΔN^                     PMID:12629552                                                                                         
  (*Drosophila melanogaster*)                                                                                                                                            

  genetic reagent\              UAS-*staufen* ^RNAi^               Vienna Drosophila\             VDRC:106645                                                            
  (*Drosophila melanogaster*)                                      Resource Center                                                                                       

  genetic reagent\              UAS-*Syp* ^RNAi^                   Vienna Drosophila\             VDRC:33012                                                             
  (*Drosophila melanogaster*)                                      Resource Center                                                                                       

  genetic reagent\              UAS-*Syp*-RB-HA                    PMID:26472907                                                                                         
  (*Drosophila melanogaster*)                                                                                                                                            

  genetic reagent\              UAS-*Imp* ^RNAi^                   Bloomington Drosophila\        BDSC:34977,\                                                           
  (*Drosophila melanogaster*)                                      Stock Center                   RRID:[BDSC_34977](https://scicrunch.org/resolver/BDSC_34977)           

  genetic reagent\              UAS-*svp* ^RNAi^                   Vienna Drosophila\             VDRC:37087                                                             
  (*Drosophila melanogaster*)                                      Resource Center                                                                                       

  genetic reagent\              UAS-*svp*                          gift from Y. Hiromi                                                                                   
  (*Drosophila melanogaster*)                                                                                                                                            

  genetic reagent\              *brat k^06028^*                    PMID:10949924                                                                                         
  (*Drosophila melanogaster*)                                                                                                                                            

  genetic reagent\              UAS-*dcr2*; *wor*-GAL4,\           PMID:21549331                                                                                         
  (*Drosophila melanogaster*)   *ase*-GAL80;\                                                                                                                            
                                UAS-CD8::GFP                                                                                                                             

  genetic reagent\              UAS-*dcr2*; *insc*-GAL4,\          PMID:21549331                                                                                         
  (*Drosophila melanogaster*)   UAS-CD8::GFP                                                                                                                             

  genetic reagent\              UAS-*stinger*::RFP                 PMID:11056799                                                                                         
  (*Drosophila melanogaster*)                                                                                                                                            

  genetic reagent\              UAS-*stinger*::GFP                 PMID:11056799                                                                                         
  (*Drosophila melanogaster*)                                                                                                                                            

  genetic reagent\              *tubulin*-GAL80^ts^                Bloomington Drosophila\        BDSC:7017,\                                                            
  (*Drosophila melanogaster*)                                      Stock Center                   RRID:[BDSC_7017](https://scicrunch.org/resolver/BDSC_7017)             

  genetic reagent\              *D. simulans*                      Drosophila Species\            14021--0251.265                                                        
  (*Drosophila simulans)*                                          Stock Center                                                                                          

  genetic reagent\              *D. willistoni*                    Drosophila Species\            14030--0814.10                                                         
  (*Drosophila willistoni)*                                        Stock Center                                                                                          

  genetic reagent\              UAS-*cherub* ^RNAi^                this paper                                                                                            RNAi against cherub
  (*Drosophila melanogaster*)                                                                                                                                            

  genetic reagent\              *cherub*^DEL^                      this paper                                                                                            full deletion of\
  (*Drosophila melanogaster*)                                                                                                                                            cherub locus

  genetic reagent\              *cherub*^promDEL^                  this paper                                                                                            deletion of promotor\
  (*Drosophila melanogaster*)                                                                                                                                            region of cherub

  genetic reagent\              cherub^genomic\ rescue^            this paper                                                                                            genomic rescue\
  (*Drosophila melanogaster*)                                                                                                                                            construct of cherub,\
                                                                                                                                                                         BAC clone CH322-116G10
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Fly strains and husbandry {#s4-1}
-------------------------

The following *Drosophila* stocks were used: UAS-*brat* ^RNAi^ (VDRC, TID 105054 and 31333), UAS-*mira* ^RNAi^ ([@bib10]), UAS-mCherry ^RNAi^ (BL35785), UAS-*lgl ^3A^* ([@bib9]), UAS-*aPKC*^ΔN^ ([@bib9]), UAS-*staufen* ^RNAi^ (VDRC,TID106645), UAS-*Syp* ^RNAi^ (VDRC, TID33012), UAS-*Syp*-RB-HA ([@bib74]), UAS-*Imp* ^RNAi^ (BL34977), UAS-*svp* ^RNAi^ (VDRC, TID 37087), UAS-*svp* (gift from Y. Hiromi), *brat ^k06028^* ([@bib4]), UAS-*dcr2; wor*-GAL4, *ase*-GAL80; UAS-CD8::GFP ([@bib84]), UAS-*dcr2; insc*-GAL4, UAS-CD8::GFP ([@bib84]), UAS-*stinger*::RFP and UAS-*stinger*::GFP ([@bib5]), *tubulin*-GAL80^ts^ (BL7017), *D. simulans* (Drosophila Species Stock Center, 14021--0251.265), *D. willistoni* (Drosophila Species Stock Center, 14030--0814.10). Stocks generated in this study: UAS-*cherub* ^RNAi^, *cherub* ^DEL^, *cherub* ^promDEL^, cherub^genomic\ rescue^. For the latter, the BAC construct CH322-116G10 was integrated into the attP40 landing site via integrase-mediated transgenesis.

If not stated otherwise, UAS transgenes were expressed at 29°C. For time-dependent induction of *brat* ^RNAi^ crosses were reared at 18°C for 6 days and then shifted at 29°C for 24 or 48 hr. For measuring cherub intensities upon *aPKC*^ΔN^ and *miranda* ^RNAi^ expression, crosses were left for 8 days at 18°C, then shifted to 29°C for 43 hr to be able to identify separate lineages and nearest daughter cells. For survival measurements, flies were raised, collected 0--3 days after eclosion and kept at 29°C. Surviving flies were counted and moved to fresh non-yeasted vials every 2--3 days. UAS-mCherry ^RNAi^ was used as control for experiments involving UAS-transgene expression, whereas *w^1118^* was used as control for comparison with mutants. For temperature-induced RNAi knockdown, the driver line was crossed to *tubulin*-GAL80^ts^ as control.

Generation of *cherub* mutants {#s4-2}
------------------------------

To create a full deletion *(cherub ^DEL^*), FRT sites were inserted upstream and downstream of the locus using the CRISPR-Cas9 system ([@bib38]) and single-stranded oligonucleotide donors. The gRNAs used were TGGCGTCGGTTCGACCGATC and ATGAAAGTGTGAATCTTCCA. Single-stranded oligonucleotide donors were ATCCTGGCAGACAATGGACAAAGCTCTAGCATCCTGATTGCGATCGGATCGCTTGGCGTCGGTTCGAAGTTCCTATTCTCTAGAAAGTATAGGAACTTCTGGCGGGTATATAAACTGCGGCTGCTGCGCAGAATCAATCAGTTTCATTTCAATCTTCAAACGCTGA and CTTTTACTTAACTGTGCTATTATTAAGTGAGGATATTTGGAAAAGGGATTCCAAATGAAAGTGTGAAGTTCCTATTCTCTAGAAAGTATAGGAACTTCCAAGGGATATTTACGAAATCTGTAATAATGGTCACCACTTCTTCAAATGGTAAGAAAAAATTAA. The FRT-flanked locus was deleted by Flp-FRT recombination ([@bib39]). Two gRNAs (GGCGTCGGTTCGACCGATC, GCCTGGACATGGCGCTGCG) were used to create a 180 bp deletion covering the promotor of *cherub* (*cherub* ^promDEL^). Mutants were verified by Sanger sequencing and PCR.

Generation of *cherub* ^RNAi^ {#s4-3}
-----------------------------

Generation of a *short hairpin RNA* line was performed according to the Transgenic RNAi Project's protocol ([@bib85]). Briefly, oligonucleotides were annealed and cloned into the Walium20 vector. The oligonucleotides used were CTAGCAGTAGACATATGGTTACTGCTCGATAGTTATATTCAAGCATATCGAGCAGTAACCATATGTCTGCG and AATTCGCAGACATATGGTTACTGCTCGATATGCTTGAATATAAC TATCGAGCAGTAACCATATGTCTACTG.

Oviposition assay {#s4-4}
-----------------

To assess female fecundity, five-day-old female virgins were crossed to two-day-old males in cages to allow mating for two days. The apple juice plate was replaced and flies laid eggs for 6 hr (9-15:00 each day). Subsequently, eggs were counted. The procedure was repeated on day 3 and 4 post mating. For each genotype three independent crosses were tested.

Viability - Eclosion rate {#s4-5}
-------------------------

Flies were allowed to lay eggs for 4 hr on apple juice plates. For each replicate 100 eggs were collected, transferred into fresh food vials and nine days later eclosed adult flies were counted daily for five days.

Negative geotaxis assay {#s4-6}
-----------------------

The climbing pass rate, which is the percentage of flies passing the 8.5 cm mark in 10 s, was assessed as described before ([@bib1]). Each replicate was measured 10 times with a 1 min rest period between measurements. For each genotype and gender, 10 biological replicates consisting each of 10 two-days old adult flies were measured.

Immunohistochemistry and antibodies {#s4-7}
-----------------------------------

Larval brains were dissected in PBS, fixed for 20 min at room temperature in 5% paraformaldehyde in PBS and washed three times with 0.1% TritonX in PBS (PBST). After 1 hr incubation in blocking solutions (1% normal goat serum in PBST), brains were incubated with primary antibodies in blocking solution overnight, then washed three times with PBST, incubated for 2 hr at room temperature with secondary antibodies (1:500, goat Alexa Fluor, Invitrogen), washed with PBST and mounted in Vectashield Antifade Mounting Medium (Vector Labs).

Antibodies used in this study were: guinea pig anti-Deadpan (1:1000, \[[@bib33]\]), rat anti-Asense (1:500, \[[@bib33]\]), guinea pig anti-Syncrip (1:500, \[[@bib79]\]), rat anti-Staufen (1:100, \[[@bib61]\]), mouse anti-PH3(Ser10) (1:1000, Cell Signalling Technologies), rat anti-Elav (1:200, DSHB 7E8A10), guinea pig anti-Miranda (1:500, \[[@bib33]\]), rabbit anti-aPKC (1:500, Santa Cruz Biotechnology), chicken anti-GFP (1:500, Abcam), rabbit anti-Imp (1:500, \[[@bib36]\]).

Fluorescence in situ hybridization (FISH) {#s4-8}
-----------------------------------------

The protocol was adapted as previously described ([@bib93]) with minor changes. Briefly, brains were fixed for 40 min. After removing the fixative with four washes of PBS, brains were permeabilized in 70% Ethanol overnight at 4°C. Ethanol was removed and 400 µl washing buffer (2x SSC, 10% Formamide) were added. After 5 min at 37°C the wash buffer was substituted by 100 µl hybridization buffer (1 mg/ml E.coli t-RNA, 2 mM Vanadyl ribonucleoside complex, 200 nM BSA, 2x SSC, 10% Formamide, 100 mg/ml Dextran sulfate) including the FISH probes. After overnight incubation at 37°C in the dark, brains were washed twice with washing buffer, each time for 30 min at 30°C. Brains were mounted in 2xSSC. The FISH probe sets against cherub were compromised of oligonucleotides labeled with a Quasar Dye (Stellaris Biosearch Technologies) and were designed using the Stellaris probe designer (<https://www.biosearchtech.com/stellarisdesigner>). DNA staining was achieved by a 20 min incubation with Hoechst (1:1000, Thermo Scientific Pierce Hoechst 33342) in washing buffer at 30°C. When antibody staining and FISH were combined, the standard immunohistochemistry protocol was performed first, followed by the FISH protocol without incubation in 70% Ethanol. FISH probe sets against cherub were compromised of the following oligonucleotide sequences:

Against all isoforms (labeled with Quasar 570 Dye):

GTGTGGAGATGCTGCAACAGGGTTGATTTTGTTCTTCTGTCGACTGAATTTTGTTGGGCTTAATCTGACATTCGGCGGTATGGTACTTGGGTTTCTTTTTGCAAATTGTTCGTTTGGCTTTGCCTTGTTGTGTTTAGTATTTTTTGCTTAAACTTAGGCTTCGCTGACATTGATTTTTTTATGCTTTGATTTCATGTGTTCAAGATGGTATCGTGGTTGTGGTACTTTGGAATTTGGTTTTTGGATATCAGCTTTCCTTATTGGTTTCAGGCGAATTACAGCCAGATGTGTTGTTAACTTATTTGTCATCTCGTGCTATTTGGGGTTCCTGTAAGATATATAGCTTTCCTTTCTTCAGATATATGGTTACTGCTCGATCCGAGTTTGATCCGGATGCAAGACAATTTCGTTGATGGGGATGCAGTAGAGAATTATGAGCAGAATTTCGTTCTTGGCGAGACGATTTTGATAGCAGTTTGGTTTGGCTGGTTGGGAATTTCGCAGTTGCTTAAGACACTGGATTTTTTGCTTGGGGCACAGGATTTCGGTGTGATTTGCTGAATTTTGGTTTCCTTCCTTGTATTTGGTTTGCGCCTGGACCCCCAGCAAAAGTGTACTTGGAGTTCATCATCATCAGCTTTCAAATGCTCGATCCTTCTCCTCCTTTCTCTTGATTATCTCTGCTTAGATATTCAGCTGGTTTTGCTGCTTGGGGTAAATATGTGGGCTGTATGTGTGTGGTGTGTGCTTGTTTGTGAATTCGGAGAGTAAAAGGTGGGC

Against isoform RA and RC (labeled with Quasar 570 Dye):

GGGGTTACTCAAATCTGTTTTTTTACTTAGTAAGGCTCCAGCTCGGTTTTAGGTTTTTGAAGTGAAATGAGGCTCACCTTGAAATTTTGCTTCTGGGCTGTGGATTTTGAGTTGTGTCGGGCCGTAGAAGAAGAGTTCGTTGGAAATGAAGCCTTCTGCGTTCAGGGATACTTTCTTTGCGGCGAACTCTTTGGTTGAATTATTGCATTGTGTGTGTGGAATTCGATTTGCGTTTTGGGATGACGAAACGCGAATTTGGACATTTGCTTGATTTTTGCATGCCATGCGAAACTGTCTTTTTGGTTGATTTGCGCCTAAAGTGAGTGTATGGGTGAGCATAAAGGGGTGTGAGTGTTTGATCTTTGCAGCCATTTTATTGCTGGGAATCGTAGAAGCAGCTGTCAGGCTATTTCTTTTCTTTTCCTATCGAACTTTTTGGGCCTATAACTCGCTTTCGTTGTAGTCCTTTCGCTAACCTATTAACTGGAGTTTGGTTTGGCAGCGCTGAGAAATGCTTGAGGCCTTTGCTTTCTTTAATGAGTGTGATTAAATAATGCCGCATTTCTATCAGCACTTCTGGTGTACTGTCGTTTGCTGTACCTTAAATGACTTCCTGGGGTTGAGTACTTAAGGGTTGGGGGTCAATGACCAGAAGACATTTTGGTCGGTCGAAGTTGTTTTCGTAATGAGGTTTGCGTTTGCTTGGCAGTATATTGATTTACCGGAATGTAGTATTTAGAAGCGTGGGTAAATAAACCAATGTGATATCGCGTTTTGGTACGATTTTTGCAATTTCGTGATTTGTTTGGCTTGATTTGGACTTCAGTGTGTTGTCGGAAAATTTTCATGATGCATAGCGATTTTGAATTTGGATGCGTGAGTGTGTGCATTATATTTTCCACCTTTTCGGATTTTGAATTGTCAATTTTATGCTCTTTGATGTGACTTTTAACGGTTTGA

Against isoform RB and RC (labeled with Quasar 570 Dye):

AGTTTTGATTACCTGGTCTGCTGCTTTGTGTGATTTTGGACATTGGTTTGGTTGGACTTTACCGAAGGTTCCTCGAAATGCTCAATTTAATGGGTGGGCTTTTTGAATTTTTGGCGGCTCCACTTCTTTTTTTCGCTCTTTTCCGCAGTTTCTTGTAATTTTTTTGCTCCTGACATTTGTCAGAAAGTTGCCAGGAGTTTCCGCCATTTCTAAGATTTTGTTTCGCTGTGATTTATCTGCCACGAGAGCTGGGAATTGTTTCAGTTTCGGTTTCAGTTTTGCAACCCTCTTCTTTGAAATGGATCAAAGTGGTCATGGTCGGCGAAAGTAATGGGCTTGAATTTGTGATTTTTGTGCGGCTGGGTTAAGTTGCAGTTTGTTGCCTTCATTTTGAGTTTGATTAAAGTTGCGGTTCTGCTGTGACACTCGTGCCGAATATTTGCCTGGAGTTTTAAGTTTCCCAAGTCTGACCACAATTTCATGGTTCGAACTTTTGCCAATTGTTTGATGTGCTTTCAGCGCTATTGCCAGTAGTTTATAATGCCAGCCATATTTTATTTGGCAACTTTTGCCATGAATTACGGTTTTTGCAGTTTCTTGGGTGATTTCGAGGGATTTTCTTGGTTTTTTCTTTTTGGGCGGTTGCTTGAATTTGCTTGACTAGCCAAAGGTGGGAAGATGCCCGAAACTTTTTTGGTAAAGATTCCATTTGCTACTCTTAGCTTTCTTTGCTTTTCTTTTATACTCGCATACTACCTGTACCTTGTGTCCGAAATGTTATTGGGTCTAAAGAGGCCTAATTCCTGTTCTTTCTTCATTTGTGGTACAATTCGCGCTTAAGTTTTCCTTTCTTTAGCATTATTCCGCAATTCAATTGCGAAAATGCGGCAATCGTTTCGTCGCTTATCACATGTGTCGAATGGTTCTTTTTTTTGTCCTGTGTTTTTGAGGTTGTACGGT

Against isoform RC (labeled with Quasar 670 Dye):

GAATTTCTATCGTGCAATCAACCTTTTCGGATTTTGAATTGTCAATTTTATGCTCTTTGATGTGACTTTTAACGGTTTGAGCAGTTTTTAATTTGGTAGTACGCGATAATTCATTTTGCTGCTGATATGTTTTTGTTTGCACATTGACATTTCTTTGCTTGTATTTCTTGGTTTGAGTTTACTGCGGTTTTTGATTGATTGTTGTTTTTGCTCTTTTTGAGTTCGTATAATGTCTTGCTCATTCGGTTCGAACTTTTGCTATCTGACATTTTACTTGGTGTTCCAATAGGGCTTTTTGTTATGTGTGTTTTGATTGTTCTGCTATCTTCATTTTGTTTCTGTTCATAGTTTTCAGTCTGAGCCTTTTGAATTGCAATCATTTTTCTCAGAACTGGTTTCATCCTGATGCATTAAGACTCTACGTTTCCATAATTGCATAAGTTCCGTTCTTTACCGGATATTTGATTTTTGTATTGCGGTAGACTGGAAGTAGTTACCTTGTAAAATGGTGGCACATGTTTTTGGTTTTCTAGACCATTTTTTTGAGATTCAAATCGGGTGTGTTATTTAAGGCATTTGGATTTGGTTTGTCTGGTTCTACAGAGGAGCCGAAAGTTGAAGGTTTTCGGTTTTCAAATTT

For confirming RNA specificity of the probe set against cherub RNA, the above mentioned standard protocol was performed except that brains were incubated for 2 hr at 37°C with RNase A (100 μg/ml) before the incubation step in 70% Ethanol or with RNase H (100 U/ml) after hybridization in order to let RNA/DNA duplexes be formed first.

In vitro FISH/Immunofluorescence {#s4-9}
--------------------------------

Cells from 25 to 35 dissociated larval brains (UAS-*dcr2; wor*-GAL4, *ase*-GAL80; UAS-CD8::GFP) were plated on cell culture dishes and incubated in complete Schneider's medium ([@bib44]) with Colcemid (25 µM) for 5 hr at 25°C. After a 15 min fixation with 5% PFA in PBS at room temperature, cells were incubated with 3% normal goat serum in 0.1% TritonX in PBS overnight, one hour with primary antibodies and one hour with secondary antibodies. Between steps cells were washed with PBS. Cells were again fixed for 20 min, washed with FISH washing buffer and FISH was performed with a probe incubation time of 4 hr at 37°C. After one wash with washing buffer for 30 min at 37°C, cells were imaged in 2xSSC. NBIIs were unambiguously identified by a size \>10 µm and GFP expression.

Microscopy and image analysis {#s4-10}
-----------------------------

Confocal images were acquired with Zeiss LSM 780 confocal microscopes. For intensity measurements of cherub foci, dot areas were marked on the plane of a z-stack with the largest diameter. Raw integrated density (sum of grey values of all selected pixels) was measured using FIJI. To determine intensity ratios in [Figure 6G and I](#fig6){ref-type="fig"}, cytoplasmic cherub of interphase NBIIs and closest daughter cells were measured as raw integrated intensities (I) using FIJI. Ratios were calculated as (I ~daughter\ cell~/area ~daughter\ cell~) / (I ~NBII~/area ~NBII~). For intensity quantifications in cross sections of cells, FIJI's plot profile function was used and the cross section length of each cell was scaled to 100%. Cortical cherub intensity in cells of 72 hr clones were measured by determining the cortex via cortical Miranda staining and measuring raw integrated intensities, which were normalized to the cortical area.

For the 3D movie, Imaris was used to 3D reconstruct a z-stack of one NBII from an in vitro FISH/IF experiment. To measure the relative position of cherub/Syp and aPKC crescents, a perpendicular line was drawn through the center of each crescent, which was defined by bisecting the connecting line between the crescent's ends (see scheme in [Figure 6E](#fig6){ref-type="fig"}). The angle between the two bisecting lines was measured using FIJI. An angle of 180°C is measured when cherub/Syp and aPKC form crescents opposite of each other (this is equivalent to a cherub/Syp crescent perpendicular to the mitotic spindle). For quantifications of tumor volumes, one brain lobe per brain was imaged and used for quantifications.

To evaluate colocalization, z-stacks were recorded of in vitro mitotic NBIIs using 63x immersion oil objective with optimal pixel size and z-stack distance. Pearson's coefficient and Li's intensity correlation analysis (ICA) were calculated using the FIJI plugin JACoP ([@bib13]). The covariance of intensity is calculated as (pixel intensity Ai -- mean intensity A)(pixel intensity Bi -- mean intensity B), A and B being the respective channels. ICA plots were made in R.

Statistics {#s4-11}
----------

Statistical analyses were performed with GraphPad Prism 7. Unpaired two-tailed Student's *t*-test was used to assess statistical significance between two genotypes/conditions and one-way ANOVA for comparison of multiple samples. No statistical methods were used to predetermine the sample size. Sample sizes for experiments were estimated based on previous experience with a similar setup that showed significance. Experiments were not randomized and investigator was not blinded.

RNA-Immunoprecipitation (RIP) {#s4-12}
-----------------------------

RIP was performed as previously described ([@bib37]) with minor modifications. Shortly, dissected brains were cross-linked with 0.5% Formaldehyde, quenched with Glycin (final 0.125 M) and homogenized in RIP lysis buffer (50 mM Hepes pH 7.5, 140 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.1% Sodium-deoxycholate, 1x protease inhibitor, 1 mM PMSF, 40 U/ml RNasin). After DNA removal using DNaseI, protein lysates were incubated overnight with antibodies (goat anti-Staufen dN-16 antibody, Santa Cruz Biotechnology or mouse anti-HA antibody clone 12CA5, in both cases 10x blocking peptide was used) at 4°C and subsequently incubated with Protein G Dynabeads (Thermo Scientific Fisher) for 1 hr. Eluted Protein-RNA complexes were treated with Proteinase K. After RNA extraction, pull-down of RNAs was detected by qPCR.

RNA isolation, cDNA synthesis and qPCR {#s4-13}
--------------------------------------

RNA was isolated by using TRIzol reagent (Ambion) or acidic Phenol/Chloroform (5:1, pH4.5, Ambion) for RIP samples. Ethanol-precipitated RNA samples were then used as template for first-strand cDNA synthesis with random hexamer primers (SuperScriptIII, Invitrogen). qPCR samples were prepared with Bio-Rad IQ SYBR Green Supermix and run on a Bio-Rad CFX96 cycler. Primers used were:

*cherub* - all isoforms (AGCAGCACCAGCAGCAGTAG, GCGGTGGATTTGGTTGATTT),

*cherub* - RC isoform (TCAAAAGGCGATGAAACCAGT, ATTGCGGTTTGTTCCGTTCT),

*brat* (CACAAGTTCGGGTGCTCTAA, CCGATTGTCGCTGATGAAGA),

*sle* (GAGTCCGTTGGCAGTAAAGATA, CTCGTCTTCGTTGTCCGATAC),

*CG42232* (GAAGATGGCGGTGAAGTAGAA, GGCCTGTAGAGCTGGAATTAG),

*CycG* (CACTACACTCACCCTTGATTCC, CGAGTTGTACGAAACCCTCAA),

*Gbs-76A* (GTCCACATCTACGGTGAGATTAC, ACCAGAGGAAAGCAGGAATG),

*CG13185* (GTCTGGAGTTCGATCAGGAAAG, GTCGGAAGCATCTGGTGTATAG),

*spen* (GAAGAGCGGCATCGACTAAA, GGCAAAGAAGGTGAGGTAGAA),

*Su(var)2-HP2* (TCCTTGGGATTCGGGAAATG, GAGGCTGCTACTGAGCTAATG),

*tai* (ACTACGGTGGCTTCAACTTC, TGGATTGCTACTGCTGCTATT),

*CG32479* (GCAAGTCCCACAGCAACTAT, CTGCGGATTGGCTGATGAA),

*Su(Tpl)* (GGTACTCATCGTAGTCGCTTTC, CGCTACGACTTCAGCCAATA),

*Taf12L* (ACAGCGATAAATCGTCGGATAA, GGACAGACTGGCTCTCAATTAC),

*CG41128* (TTAAAGGATGTGGAGGCGTAAT, TCCTATAAGCGATGCCCATTC),

*Hsp67Ba* (GCCAGCAATCTCCCACTATT, AATAATCTGCACGGGTAGGC),

*CG2021* (CATGAGCGCGTCTTCTCTAC, AGTCGATGGTCTCGTCTATCA),

*CG11882* (ACTAACAGCGTCAGCTTCTC, GAGCCTGATGAAGGGCTATT).

Gene expression was normalized to *Act5C*

(AGTGGTGGAAGTTTGGAGTG, GATAATGATGATGGTGTGCAGG).

Primers used for RIP-qPCR were:

*RpL32* (GCCGCTTCAAGGGACAGTAT, TTCTGCATGAGCAGGACCTC),

*cherub* - all isoforms (AGCAGCACCAGCAGCAGTAG, GCGGTGGATTTGGTTGATTT).

Primers for RT-PCR (30 cycles) used to detect expression in different *Drosophila* species were:

for *GPDH:*

*D. melanogaster* (AACTTCTGCGAAACGACAAT, CGTAACACGTCGTGATCAG),

*D. simulans* (AACTTCTGCGAAACGACAAT, CGTAACACGTCGTGATCAG),

*D. willistoni* (ATACCATGCGCCGTACTG, CATAACACGTCGTGATAAGATCC),

for *cherub*

*D. melanogaster* (AGCAGCACCAGCAGCAGTAG, GCGGTGGATTTGGTTGATTT),

*D. simulans* (GAGTAGGAGCCGCACAGGAG, CGGTGTGGAGATGCTGCAAC),

*D. willistoni* (GGAAGGATCTATGCAGAGAGAGACA, CCCCAACCTTCTTGTGTCCG).

Immunoprecipitation and western blotting {#s4-14}
----------------------------------------

Immunoprecipitation was performed according to the RIP protocol except omission of formaldehyde fixation, DNaseI treatment steps and instead of RNA isolation samples were boiled in 2x Laemmli buffer to elute protein complexes and loaded on 3--8% gradient Tris-Acetate gels (NuPAGE, Invitrogen). After SDS-PAGE according to Invitrogen's protocol, proteins were transferred to a Nitrocellulose membrane (0.22 µm, Odyssey LI-COR) for 2 hr at 100V, blocked with 5% milk powder in blocking solution (PBS with 0.2% Tween) for 1 hr, overnight incubation with primary antibody in blocking solution at 4°C, 3x washed with washing solution (PBS with 0.1% Tween) and followed by 1 hr incubation with secondary antibody (HRP-linked Whole Antibodies from GE Healthcare) in blocking solution. After three washes with washing solution, horseradish peroxidase activity was detected with Pierce ECL Plus (Thermo Fisher Scientific). Antibodies used were: goat anti-Staufen (1:2000, dN-16 Santa Cruz Biotechnology), guinea pig anti-Syncrip (1:3000, ([@bib79])), mouse anti-HA (1:500, clone 12CA5).

PhyloCSF analysis {#s4-15}
-----------------

A Multiz alignment of 27 insecta (23 *Drosophila* species, house fly, *Anopheles gambiae* and *mellifera*, honey bee and *Tribolium castaneum*) aligned to *Drosophila* genome dm6 in multiple alignment format (MAF) was downloaded from UCSC Genome Browser. The strand specific gene models of the mentioned genes (FlyBase r6.09) were provided as BED files. Those inputs were used in Galaxy ([@bib11]) in 'Stitch MAF blocks' followed by 'concatenate FASTA alignment by species' functions to generate FASTA alignments for each gene in the 12 *Drosophila* specified by the PhyloCSF phylogeny. PhyloCSF ([@bib73]) was run with the resulting FASTA file using the following parameters: '\--orf=ATGStop \--frames=3 removeRefGaps \--aa'.

Transplantations {#s4-16}
----------------

Crosses were set up at 29°C. Third-instar larval brains were collected after 5--6 days, NBs were isolated by FACS ([@bib43]) and transplantations of GFP^+^ NBs (UAS-*dcr2; insc*-GAL4, UAS-*stinger*::GFP) or RFP^+^ tNB (*brat* ^RNAi^ driven by UAS-*dcr2; wor*-GAL4, *ase*-GAL80; UAS-*stinger*::RFP) suspensions were performed as previously described ([@bib21]) with minor modifications. Pictures of transplanted host flies were taken with a Sony Alpha NEX-5 compact camera.

DNA content analysis {#s4-17}
--------------------

Dissected brains were enzymatically dissociated in Rinaldini solution as described previously ([@bib8]) and incubated with Hoechst 33342 (20 µM) for 1 hr at room temperature. Then samples were kept on ice until FACS sorting. Data plots were generated with FlowJo software.

Sample preparation for whole-genome sequencing {#s4-18}
----------------------------------------------

Genomic DNA was isolated from the dissected tumor brains and abdomens of the same adult female *brat* ^k06028^ fly using standard Phenol-Chloroform extraction procedure including RNase and Proteinase K treatment. In total, three flies were sequenced. DNA was fragmented using a microtip sonicator (Omni-Ruptor 250, Omni International). Quality control was performed with Agilent High Sensitivity DNA Kit (Agilent Technologies). DNA libraries were prepared using NEBNext Ultra DNA Library Prep Kit (Illumina) and 100 base pair paired-end sequencing was performed on a Hiseq2000 platform. After deduplication, an average sequencing depth of \>170 x was achieved for each sample. Sequence data has been deposited at the short read archive (<https://www.ncbi.nlm.nih.gov/sra>, SUB1954694).

Analysis of whole-genome sequencing data {#s4-19}
----------------------------------------

Leading and trailing Ns of the paired reads were trimmed. Reads were aligned with BWA (v0.6.2) ([@bib71]) to the genome (FlyBase r5) with a maximum insert size of 1000. Picard tools (v1.82, <http://broadinstitute.github.io/picard>) were used to fix the alignment (CleanSam) and add read groups (AddOrReplaceReadGroups). Duplicates (MarkDuplicates) were marked within all samples derived from the same fly. Reads of a fly were realigned with GATK (v2.3) for each chromosome and remerged with Picard tools. Summary statistics were computed with GATK ([@bib81]). Somatic point mutations were identified with MuTect (v1.1.4) ([@bib24]). InDels (strand.bias = TRUE) were identified with the SomaticIndelDetector of GATK. Variants were characterized with SnpEff (v3.2a) ([@bib26]). For coverage plots, reads were counted in genomic bins and normalized by the median. The foldchange and coverage were plotted with R. Published aCGH datasets were used to identify under-replicated ([@bib102]) and amplified ([@bib55]) regions.

RNA sequencing -- DigiTAG {#s4-20}
-------------------------

We devised a method that combines transposon-mediated library preparation with molecular barcoding to quantify the original library molecules rather than their amplicons ([Figure 3B](#fig3){ref-type="fig"}). The NBII driver line UAS-*dcr2; wor*-GAL4, *ase*-GAL80; UAS-*stinger*::RFP was used. Brains from wandering third instar larvae were dissected, dissociated and NBs were isolated by FACS ([@bib8]; [@bib43]). For each condition, three samples were prepared. RNA from 300 cells per sample was used for library preparation. Total RNA isolated with TRIzol LS reagent (Ambion) was reverse transcribed into first strand cDNA using Superscript III Reverse Transcriptase (Invitrogen) with oligo-(dT)20 primers. After second strand synthesis was performed, the sequencing library was prepared with the Nextera DNA Library Preparation Kit (Illumina). In an enzymatic tagmentation reaction, cDNA was simultaneously fragmented and tagged with adapter sequences: 15 µl TDE1 Tagment DNA buffer, 0.2 µl TDE1 Tagment DNA enzyme was added to 15 µl cDNA and incubated for 5 min at 55°C. After purification (Agencourt AMPure XP beads, Beckman Coulter), 19.5 µl tagmented DNA was PCR amplified using 25 µl Phusion HF 2x master mix (Thermo Fisher Scientific), 2.5 µl 20x Eva Green (Biotium), 1 µl Nextera primers mix (10 µM each), 1 µl Index two primers (N501-N506, for multiplexing) and 1 µl modified Index one primers, which included random 8-mer tags for molecular barcoding. Cycling conditions according to the manufacturer (Nextera DNA Library Preparation Kit, Illumina) were used. Purified libraries (Agencourt AMPure XP beads) were subjected to 50 base pair Illumina single-end sequencing on a Hiseq2000 platform.

Transcriptome data analysis {#s4-21}
---------------------------

The reads were screened for ribosomal RNA by aligning with BWA (v0.6.1) ([@bib71]) against known rRNA sequences (RefSeq). The rRNA subtracted reads were aligned with TopHat (v1.4.1) ([@bib110]) against the *Drosophila melanogaster* genome (FlyBase r5.44) and a maximum of 6 mismatches. Introns between 20--150000 bp were allowed which is based on FlyBase statistics. Maximum multihits was set to one and InDels as well as Microexon-search was enabled. Additionally, a gene model was provided as GTF (FlyBase r5.44). snRNA, rRNA, tRNA, snoRNA and pseudogenes were masked for downstream analysis. Reads arising from duplication events were marked as such in the alignment (SAM/BAM files) as follows: The different tags were counted at each genomic position. Thereafter, the diversity of tags at each position was examined. First, tags were sorted descending by their count. If several tags had the same occurrence, they were further sorted alphanumerically. Reads sharing the same tag, were sorted by the average PHRED quality. Again if several reads had the same quality, they were further sorted alphanumerically. Now the tags were cycled through by their counts. Within one tag, the read with the highest average PHRED quality was the unique correct read and all subsequent reads with the same tag were marked as duplicates. Furthermore, all reads which had tags with one mismatch difference compared the pool of valid read tags were also marked as duplicates. The aligned and deduplicated reads were counted with HTSeq ([@bib3]; [@bib72]) and the polyA containing transcripts were subjected to differential expression analysis with DESeq (v1.10.1) ([@bib2]). Note that the basemean values of *brat* mRNA appear unchanged in *brat *^RNAi^ NBII compared to control NBII. We attribute this to a large number of reads, unique to the *brat* ^RNAi^ condition, matching non-coding regions in the second intron of *brat-RA*, *-RE*, and the first intron of *brat-RB*, *-RC*. Conversely, reads matching the coding region of the gene are reproducibly lower in *brat* ^RNAi^ condition. Furthermore, *brat* knockdown was confirmed by qPCR targeting a coding region. Data has been deposited in the data depository Gene Expression Omnibus (<http://www.ncbi.nlm.nih.gov/geo/>, GEO serial accession number GSE87085). To investigate the expression of early temporal NB identity genes ([Figure 8A](#fig8){ref-type="fig"}) in tNBs we made use of a previously published gene dataset from antenna lobe NBs ([@bib74]).

Sequence identity, conservation and RNA structure analysis {#s4-22}
----------------------------------------------------------

The Multiz alignment of 27 insects was accessed for the genomic locus via the UCSC table browser. The MAF blocks are stiched in Galaxy ([@bib12]). Percent of sequence identity defined as '100 \* (identical positions) / (aligned positions + internal gap positions)' was calculated with Biostrings in R (R package version 2.40.2.). *Drosophila suzukii* was excluded due to a very small homology region. Thermodynamically stable and evolutionary conserved RNA structures were predicted using the RNAz Web server ([@bib41]) using step size 10 and a window size of 200. Sequence repeats were identified by RepeatMasker ([@bib52]) and conservation was assessed by PhastCons and PhyloP ([@bib103]) via the UCSC Genome Browser (dm6).
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Major datasets {#s7}
--------------

The following datasets were generated:

Lisa LandskronJürgen A KnoblichThomas R Burkard2017brat tumor sequencing<https://www.ncbi.nlm.nih.gov/sra/?term=SRP090130>Publicly available at the NCBI Sequence Read Archive (accession no. SRP090130)

Francois BonnayThomas R BurkardJürgen A Knoblich2017NBII vs tNB transcriptome<https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE87085>Publicly available at the NCBI Gene Expression Omnibus (accession no. GSE87085)

The following previously published datasets were used:

Sher NBell GWLi SNordman JEng TEaton MLMacalpine DMOrr-Weaver TL2012CGH to ascertain levels of gDNA in third instar salivary glands of various mutant Drosophila<https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE31900>Publicly available at the NCBI Gene Expression Omnibus (accession no. GSE31900)

Kim JCNordman JXie FKashevsky HEng TLi SMacAlpine DMOrr-Weaver TL2011Input DNA from OregonR\^TOW Stage 10 egg chambers<https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE29517>Publicly available at the NCBI Gene Expression Omnibus (accession no. GSE29517)

10.7554/eLife.31347.033

Decision letter

Bellen

Hugo J

Reviewing Editor
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"The asymmetrically segregating lncRNA cherub is required for transforming stem cells into malignant cells\" for consideration by *eLife*. Your article has been favorably evaluated by K VijayRaghavan (Senior Editor) and three reviewers, one of whom, Hugo Bellen, is a member of our Board of Reviewing Editors. The reviewers have opted to remain anonymous.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

The paper addresses an interesting question in tumor biology: How do tumor cells become immortal? The authors show that a lncRNA (cherub) is upregulated in tumorous neuroblasts compared to wild type, and that it plays a crucial role in the immortality of tumor cells. Interestingly, this lncRNA is dispensable for normal development and the flies are fully fertile and healthy. The authors also present evidence that the cellular localization of cherub during neuroblast divisions is the critical factor for cherub to be tumorigenic in a brat background. cherub is localized asymmetrically in dividing neuroblasts where it is enriched at the cell cortex, and it is inherited in daughter cells where it is cytoplasmic in newborn intermediate precursors of Type II neuroblasts. The gene is increased in brat mutant neuroblasts, which leads to increased expression in INP, which might return to neuroblast fate. Two RNA binding proteins Syp and IMP have been proposed to regulate the age of the neural stem cells by others, with opposing gradients over time. Here they show that IMP and Syp have some altered levels/distribution in the tumors from loss of Brat; this is less clear for Syp than for IMP. They propose that Syp is involved in linking Syp to Staufen: they detect binding of Syp to staufen in RIP, which is reduced in the absence of cherub. The resulting model is that, by linking Staufen to Syp, cherub contributes to the mechanism of neural stem cell aging, so that in its absence the NBs/tNBs adopt a younger character more prone to tumors. The model is an attractive one, but not all the supporting data are clear-cut nor is the fit between the model and the data straightforward. However, the study is significant to the field of tumor biology, as well as for a more general understanding of the molecular function of lncRNAs.

Comments:

1\) The authors are careful to use two deletions and an RNAi line for cherub, but a genomic rescue construct should restore tumor formation in brat/cherub mutants. The authors should show this control.

2\) Is overexpression of cherub sufficient to drive tumorigenesis or increase proliferation? Please provide data.

3\) Failure to detect a peptide in proteomic analyses does not necessarily mean the peptide is not made. How confident are the authors that no small peptides exist for cherub? See Zanet J, et al. (2015) Science 349:1356-1358 for another outcome.

4\) [Figure 6F](#fig6){ref-type="fig"}: While one can identify cortical cherub in Lgl3A, it is difficult to detect differences in neuroblasts of the other three panels, especially in print. Similarly, in [Figure 6G](#fig6){ref-type="fig"}, accumulation of cherub in staufen knockdown neuroblasts is obvious, but no evidence of asymmetric segregation failure. This should be more convincingly shown.

5\) The authors mention that \"Small insertions and deletions (InDels) were mainly restricted to introns or intergenic regions\" and consider such changes as insignificant in terms of tumorigenesis. However, we know that changes in regulatory regions could be meaningful as they could be templates for transcription factors or ncRNAs.

6\) Subsection "Tumor neuroblasts show defects in temporal neuroblast identity and require early temporal factors", first paragraph, shouldn\'t it be tNBs instead of NBIIs? It seems like despite tNBs being collected at late larval stages, they still express genes usually restricted to early NBs. The authors argue that cortical localization of cherub is, \"enhanced in brat tNBs\" -- this is not evident in [Figure 7](#fig7){ref-type="fig"}. Likewise that \"extra tNBs had strongly elevated cortical cherub\" is also not clear in [Figure 7](#fig7){ref-type="fig"}. Proper quantification of these results are needed as they are pivotal to their model. Please address.

7\) Subsection "Tumor neuroblasts show defects in temporal neuroblast identity and require early temporal factors", first paragraph, the authors refer to [Figure 8A](#fig8){ref-type="fig"}. The way this figure is presented is not very clear. The authors write in the figure legend \"see Materials and methods\". However, I cannot find where in the Materials and methods part this is described, and what methods were used for the evaluation.

8\) There appears to be a gap in the model, the authors do not really explain how/why the presence of cherub \"rejuvenate\" the NBs via its effects on Syp. This is a key point that the authors need to address. For example, cherub is proposed to bind to Syp linking it to Staufen so that it segregates correctly. Knock down of cherub perturbs Syp segregation, but gives the opposite phenotypes (Syp KD enhances the tumors, cherub KD reduces them). A clearer explanation for their interpretation of these data is needed. The model also makes the prediction that Staufen KD should have the same effects on tumorigenesis as cherub, is this the case? What happens if both Syp and cherub are knocked down at the same time?

9\) The effects of removing Staufen on Syp are much more pronounced than removing cherub, how do the authors explain this difference ([Figure 9D, E](#fig9){ref-type="fig"}).

10\) Was Imp also detected in the RIP? Imp also is affected by cherub knock-down and the phenotypes of IMP KD are more similar to cherub KD. How do they explain this? More experiments or at least discussion of the relationship with IMP are needed.

11\) If cherub is involved in regulating the temporal state of the stem cells, is the expectation that early induced brat tumors would not be suppressed by cherub KD? The authors should investigate effects at earlier stages to verify their model.

12\) The model implies that cherub, Staufen and Syp will co-localize in the crescent, but this has not been shown.

10.7554/eLife.31347.034

Author response

> Comments:
>
> 1\) The authors are careful to use two deletions and an RNAi line for cherub, but a genomic rescue construct should restore tumor formation in brat/cherub mutants. The authors should show this control.

We have generated transgenic flies harboring a cherub genomic rescue construct. Using this line, we were able to revert the tumor rescue phenotype of cherub. Our observation is that the rescue construct can increase the number of Dpn+ tNBs in in brat^RNAi^ cherub ^DEL-/-^ brains. These data are now included in [Figure 5---figure supplement 1D](#fig5s1){ref-type="fig"}. Importantly, the new data not only verify the specificity of our mutant alleles but they also demonstrate that cherub can exert its tumor-suppressive function when inserted at another genetic location.

> 2\) Is overexpression of cherub sufficient to drive tumorigenesis or increase proliferation? Please provide data.

We agree that the overexpression of cherub would be very informative. We have made transgenic flies overexpressing the longest or the shortest cherub isoform. Cherub expression from this inducible transgene using the UAS/GAL4 system did not lead to the formation of stable cherub transcripts in the cytoplasm or at the cortex, although we detected an additional nuclear dot with FISH probes against cherub indicative of successful transgene transcription (see [Author response image 1](#respfig1){ref-type="fig"}). We would like to mention that this phenomenon has been also described for other temporal factors. It has been shown for both, Imp and Syp, that expressing them from an overexpression construct in NBs only weakly -- if at all --increases expression (Liu et al., 2015; Yang et al., 2017a). Thus, the temporal identity programs in central brain NBs are tightly regulated on a post-transcriptional level.

![Overexpression of cherub RA isoform with UAS-dcr2; wor-GAL4, ase-GAL80; UAS-CD8::GFP.\
The combination of isoform-specific FISH probes allows the detection of the transgene in the nucleus (arrow). Thus, the transgene is induced in NBs despite the lack of elevated cherub levels in the cytoplasma/cortex. Scale bars 10 μm.](elife-31347-resp-fig1){#respfig1}

> 3\) Failure to detect a peptide in proteomic analyses does not necessarily mean the peptide is not made. How confident are the authors that no small peptides exist for cherub? See Zanet J, et al. (2015) Science 349:1356-1358 for another outcome.

Additionally, to proteomic analysis we showed that cherub isoforms have a negative (non-coding) maxCSF score, a measurement that also takes into account the evolutionary signature of 12 *Drosophila* species and has been used in other studies to assess the coding potential of lncRNAs (e.g. (Lee et al., 2016; Li et al., 2012)). Likewise, coding potential calculator, an algorithm that has been shown to correctly predict the coding potential of the polished rice RNAs mentioned by the reviewer (Ríos-Barrera et al., 2015), assigns negative hit scores (non-coding) to all cherub isoforms (RA:-0.86, RB-0.89:, RC:-0.92). Furthermore, we show a function for the cherub RNA (binding between Staufen and Syncrip) and its presence in complexes involved in the proposed function. Altogether, this strongly suggests a non-coding function, although we cannot formally rule out that also peptides are made. In the main text we already suggested "Thus, CR43283 likely acts as a lncRNA." and now we modified the text further to "Peptides of short open reading frames found in CR43283 were not detected in the brat tumor proteome and PhyloCSF analysis of CR43283 did not reveal any coding potential" -- please see subsection "The lncRNA cherub is upregulated in tumor neuroblasts compared to type II neuroblasts".

> 4\) [Figure 6F](#fig6){ref-type="fig"}: While one can identify cortical cherub in Lgl3A, it is difficult to detect differences in neuroblasts of the other three panels, especially in print. Similarly, in [Figure 6G](#fig6){ref-type="fig"}, accumulation of cherub in staufen knockdown neuroblasts is obvious, but no evidence of asymmetric segregation failure. This should be more convincingly shown.

To address this point, we reasoned that if cherub is distributed symmetrically during mitosis, the resulting two daughter cells (NBII and INP) should have similar amounts of cherub. Whereas if cherub is cortical and thus asymmetrically segregated, cherub levels should be higher in the most recently born INP when compared to the NBII. Indeed, measuring cytoplasmic cherub intensity upon loss of staufen revealed equal levels in NBII and surrounding INP, confirming that Staufen is important for asymmetrically allocating cherub. These results are presented in [Figure 6I](#fig6){ref-type="fig"}. In addition, we also provide now images of a staufen ^RNAi^ NB in mitosis, which does not show a basal cherub crescent. Please see [Figure 6---figure supplement 2C](#fig6s2){ref-type="fig"}.

Similarly, we measured cytoplasmic cherub intensities in NBIIs and daughter cells upon *miranda*^RNAi^ or aPKCΔN expression. Under both conditions, we detected equal signal intensities for cherub in the two daughter cells indicating similar cherub concentrations in both cells. These data strengthen the results in [Figure 6G](#fig6){ref-type="fig"} and show that the canonical asymmetric cell division machinery is required for cherub's asymmetry.

> 5\) The authors mention that \"Small insertions and deletions (InDels) were mainly restricted to introns or intergenic regions\" and consider such changes as insignificant in terms of tumorigenesis. However, we know that changes in regulatory regions could be meaningful as they could be templates for transcription factors or ncRNAs.

We apologize if it may have sounded as if we disregard InDels found in introns and intergenic regions due to their nature. Rather we suggest that we did not find recurrent DNA changes (including InDels) as we did not identify a region (defined as 10000bp), that harbored InDels in all tumor samples. Therefore, it is unlikely an element common to all tumors is affected by this InDels. We have modified the text to clarify this.

> 6\) Subsection "Tumor neuroblasts show defects in temporal neuroblast identity and require early temporal factors", first paragraph, shouldn\'t it be tNBs instead of NBIIs? It seems like despite tNBs being collected at late larval stages, they still express genes usually restricted to early NBs. The authors argue that cortical localization of cherub is, \"enhanced in brat tNBs\" -- this is not evident in [Figure 7](#fig7){ref-type="fig"}. Likewise that \"extra tNBs had strongly elevated cortical cherub\" is also not clear in [Figure 7](#fig7){ref-type="fig"}. Proper quantification of these results are needed as they are pivotal to their model. Please address.

Yes, correctly it should be tNBs. We have corrected this mistake (subsection "Tumor neuroblasts show defects in temporal neuroblast identity and require early temporal factors") and also included now quantifications to make the data in [Figure 7](#fig7){ref-type="fig"} more evident. We measured cherub levels in cross sections of cells. These measurements show that in brat tNBs cortical cherub is elevated. This data can be found in [Figure 7---figure supplement 1B](#fig7s1){ref-type="fig"}. It seems that [Figure 7F](#fig7){ref-type="fig"} is confusing as the point we wanted to make here is that the tNBs have increased cortical cherub compared to the NBII. We provide 72h instead of 48H clones since at 72h more tNBs have reached a NB-like size and this will guide the reader better to compare it to the correct wildtype cell, which is the NBII. Furthermore, we quantified cortical cherub levels in these NBs to clearer show the accumulation of cherub in tNBs -- please see new [Figure 7G](#fig7){ref-type="fig"}.

> 7\) Subsection "Tumor neuroblasts show defects in temporal neuroblast identity and require early temporal factors", first paragraph, the authors refer to [Figure 8A](#fig8){ref-type="fig"}. The way this figure is presented is not very clear. The authors write in the figure legend \"see Materials and methods\". However, I cannot find where in the Materials and methods part this is described, and what methods were used for the evaluation.

The same data are now depicted in a new graph and we hope it is now easier to understand. We removed the "see Materials and methods" as it leads to confusion. The analyses of differential coverage and the reference for the list of early NB identity genes can be found at the very end in the Materials and methods part "Transcriptome data analysis".

> 8\) There appears to be a gap in the model, the authors do not really explain how/why the presence of cherub \"rejuvenate\" the NBs via its effects on Syp. This is a key point that the authors need to address. For example, Cherub is proposed to bind to Syp linking it to Staufen so that it segregates correctly. Knock down of cherub perturbs Syp segregation, but gives the opposite phenotypes (Syp KD enhances the tumors, cherub KD reduces them). A clearer explanation for their interpretation of these data is needed. The model also makes the prediction that Staufen KD should have the same effects on tumorigenesis as cherub, is this the case? What happens if both Syp and cherub are knocked down at the same time?

Our data suggest that the loss of cherub leads to enriched cytoplasmic Syp in tNBs and a reduction in tumor growth, while the depletion of Syp in tNBs has the opposite effect and enhances tumor growth. These results suggest that Syp promotes tumor growth. cherub might inhibit Syp directly by binding to it and/or indirectly by removing Syp from the tNB. Syp has been shown to bind many different mRNA targets and to regulate their translation either negatively or positively (McDermott et al., 2014). The direct targets of Syp in the brain are currently unclear. However, genetic experiments showed that Syp represses early NB factors like Imp (Syed et al., 2017; Yang et al., 2017a) and also promotes the expression of genes restricting NB proliferation (Yang et al., 2017a; 2017b). cherub is likely to inhibit the latter one for two reasons: 1) We have shown that in brat tumors high cherub levels recruit Syp to the cortex, but only a minor subset expresses Imp. 2) We performed immunostainings showing that cherub mutant NBIIs do not show a change in expression or timing of Imp (data not shown). In the subsection "cherub regulates Syp locatization in brat tumors", we now provide an extensive discussion to explain this.

We have tested the knock down of staufen in brat tumors and could not see differences in tumor growth. At the current state, we can only speculate why this is. Importantly, in a cherub knockdown situation NBs have high cytoplasmic levels of Syp, whereas in a staufen knockdown condition NBs have high cytoplasmic cherub and Syp. This indicates that cherub inhibits Syp function.

Unfortunately, due to difficulties in generating the appropriate fly stocks, it was not possible to perform Syp cherub double knockdown experiments in a brat tumor background within a reasonable time frame.

> 9\) The effects of removing Staufen on Syp are much more pronounced than removing cherub, how do the authors explain this difference ([Figure 9D, E](#fig9){ref-type="fig"}).

Our interpretation of these results is that in both of these conditions, the neuroblast shows enriched cytoplasmic cherub and -- unlike in control NB lineages -- cherub is not enriched in the latest born INP. This indicates a failure to distribute Syp asymmetrically between NBII and INP. We did recognize that cherub levels are decreased in the daughter cells of staufen depleted NBs. It should be noted that staufen has been shown to bind many RNAs and thus might show a more complex phenotype. Staufen depleted NBs appear less healthy in general: They show a deformed NB shape and have irregular nuclei with membrane protrusions into the nucleus, which can be best seen in [Figure 6H](#fig6){ref-type="fig"}. A delay in NB division would explain the different cherub concentrations in NB and INP as while cherub is readily degraded in INPs it accumulates in NBs.

> 10\) Was Imp also detected in the RIP? Imp also is affected by cherub knock-down and the phenotypes of IMP KD are more similar to cherub KD. How do they explain this? More experiments or at least discussion of the relationship with IMP are needed.

We have preliminary data suggesting that Imp might co-immunoprecipitate with Staufen as well. However, NBs of cherub mutants did not show any defects in Imp localization or in the timing of Imp expression. In contrast, Syp levels within the NB lineage clearly depend on the Staufen-cherub complex and were altered in cherub mutants. For those reasons, we did not investigate Imp further. The relationship between Imp, Syp and cherub is now discussed in more detail in the Discussion of the manuscript. See subsection "cherub regulates Syp locatization in brat tumors" and comment \#8.

> 11\) If cherub is involved in regulating the temporal state of the stem cells, is the expectation that early induced brat tumors would not be suppressed by cherub KD? The authors should investigate effects at earlier stages to verify their model.

We think this comment is due to a misunderstanding as all our tumors are induced early and we would like to clarify this:

The Maurange lab has shown that an early tumor induction is required to develop malignant tumors. However, even the majority of tumor cells of early-induced tumors progress over time to a Syp^+^Imp^-^ state. Only a small fraction of tNBs express Imp at this time (Narbonne-Reveau et al., 2016). Rather than influencing the temporal state of the NB in which the tumor is induced, we suggest that cherub regulates temporal fate transitions in tNBs. Loss of cherub enhances the progression towards an "aged" tNB with less growth capacity.

> 12\) The model implies that cherub, Staufen and Syp will co-localize in the crescent, but this has not been shown.

We showed that cherub and Syncrip localize at the same cell pole of mitotic NBIIs by measuring the position relative to the apical cell pole (see [Figure 6D, E](#fig6){ref-type="fig"}, [Figure 6---figure supplement 1I](#fig6s1){ref-type="fig"} and [Figure 9C](#fig9){ref-type="fig"}). These results already indicate that cherub and Syncrip localize at the basal cell pole like it has been extensively described for Staufen in the literature (and also [Figure 6---figure supplement 2A](#fig6s2){ref-type="fig"}).

To strengthen this point, we now further included immunostainings showing the colocalization of these 3 gene products. Additionally, we also quantified the colocalization by determining the Pearson's coefficient for NBIIs and performed intensity covariance analysis. These analyses suggest not only that all three localize to the basal crescent, but also that their intensities correlate. All new data can be found in [Figure 9---figure supplement 1](#fig9s1){ref-type="fig"}.
